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Abstract 
Obesity is a major public health problem worldwide of increasing prevalence. It is 
characterised by a low grade chronic inflammatory state, which contributes to 
obesity-associated morbidity. A body of evidence suggests that obesity is associated 
with periodontitis, and is second only to smoking as a risk factor for periodontal 
tissue destruction, but underlying biological mechanisms for this association remain 
unclear. Adipose tissue functions as an endocrine organ, secreting cytokines 
(adipokines) that are reported to be associated with dysregulated/inflammatory 
immune responses to bacterial challenge. Adipokines include tumour necrosis factor 
alpha (TNFα), adiponectin, resistin, leptin and interleukin-6 (IL-6), all of which have 
been shown to prime/affect neutrophils for a secondary stimulus. Neutrophils are the 
major cell type involved in periodontal immunity to infectious agents. This study 
therefore aimed to elucidate neutrophil reactive oxygen species (ROS) and 
neutrophil extracellular trap (NET) responses to bacterial stimulation in an adipokine 
rich (obese) verses an adipokine normal (lean) environment. Blood was isolated from 
healthy male volunteers, with no history of diabetes and with normal body mass 
indices (BMI’s) (range 20-25). Peripheral blood neutrophils were isolated by 
Percoll
TM
 discontinuous gradient centrifugation, primed with TNFα, adiponectin, 
resistin, leptin or IL-6, alongside control two control stimuli GM-CSF and IL-8, at 
concentrations reflective of lean and obese individuals. Neutrophils were 
subsequently stimulated with Fusobacterium nucleatum (ATCC 10953) for Toll-
Like receptor (TLR)-4 activation, opsonised Staphyloccocus aureus (NCTC 6571) 
for FcγRII activation or phorbol 12-myristate 13-acetate (PMA) for direct activation 
via protein kinase C (PKC). Neutrophil ROS were measured by luminol enhanced 
and chemiluminsecence and NET release was by fluorometric assay of DNA and 
fluorescence microscopy. Adipokine concentrations representative of those found in 
obese individuals have been shown in this pilot study to enhance neutrophil ROS and 
NET generation after exposure to bacterial stimulus. The effects are however 
stimulus dependent and require longer studies to validate any significant results. 
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1. Introduction 
1.1  Periodontitis 
 
Inflammatory periodontitis is one of several diseases that affect the periodontal 
tissues. The disease is initiated by bacteria within a subgingival biolfilm but 
progresses because of aberrant host inflammatory immune responses to the biofilm 
organisms which fail to re-establish a “health-associated” biofilm. Both 
environmental lifestyle (Palmer et al. 2005) and genetic factors (Michalowicz et al. 
1991) are thought to contribute to the dysregulation. Periodontitis lesions share many 
of the characteristics of the preceding gingivitis, which remains confined to the 
gingival tissues and is reversible inflammation (Armitage 2000), however 
destruction of the connective tissue attachment to the teeth, resorption of alveolar 
bone and tooth loss are specific to periodontitis (Listgarten 1986). Alveolar bone 
resorption occurs when levels of inflammatory mediators in the overlying soft tissues 
reach a certain threshold at a critical distance from the bone surface and activate 
pathways leading to the breakdown of bone (Graves and Cochran 2003). Figure 1.1 
illustrates the effects of periodontitis. 
The accumulation of a plaque biofilm within the oral cavity elicits an inflammatory 
immune response by the host which leads to the formation of an “initial lesion” (Löe 
et al. 1965: Theilade et al. 1966), neutrophils and other immune cells are recruited to 
the lesion by chemokines, cytokines and other stimulatory molecules secreted by 
cells within the affected tissues. Enhanced accumulation of neutrophils has been 
reported in the gingival tissues of patients with periodontitis (Liu et al. 2001). 
Lesions that become “established” are accompanied by changes in the dominant 
immune cell infiltration, such as the transition of T cells to B cells, which is also 
mediated by cytokines (Gingivitis, 1999).   
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Chronic periodontitis is a major cause of tooth loss and is significantly associated 
with other diseases including type II diabetes (Herring and Shah 2006), rheumatoid 
arthritis (Pischon et al. 2008) and cardiovascular diseases (Pihlstrom et al. 2005).  
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Figure 1.1 The differences between healthy and periodontitis tissues (Darveau 2010). 
The tissue to the left represents a healthy individual, with the oral epithelium 
covering the supportive connective tissue which is bound to the tooth surface by 
junctional epithelium. The right side of the diagram represents a periodontitis 
sufferer; the accumulation of plaque bacteria results in the destruction of the 
connective tissue resulting in eventual tooth loss. 
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1.2  Bacteria in periodontal disease 
 
Oral tissues are constantly exposed to bacteria and their products; the soft and hard 
tissues in such close proximity create a niche in which bacteria can survive, multiply 
and colonise (Bolstad et al. 1996). More than 400 bacterial species have been 
cultured from periodontal pockets and plaque biofilms and 1,200 phylotypes have 
been identified by molecular methods (Dewhirst et al. 2010), however few are 
implicated in disease (Signat et al. 2011). Characteristics of pathogenic periodontal 
bacteria include the ability to colonise, evade the host immune system and release 
virulence factors that inadvertently induce an inflammatory response. This response 
can initiate tissue destruction and also provide an environment for more virulent 
microorganisms to colonise. From the early to late stages of plaque formation within 
the gingival crevice there is a shift from Gram positive to Gram negative colonisers 
(Ritz 1967) such as Porphymonas gingivalis and Fusobacterium species (Socransky 
et al. 1998). 
 
1.3  The host immune response in periodontal disease: the neutrophil 
 
The immune response to the pathogenic bacteria that colonise periodontal tissues 
involves both the adaptive and innate systems. Along with eosinophils and basophils, 
neutrophils form the granulocyte family of innate white blood cells (Ehrlich 1880) 
comprising 50-60% of total circulating leukocytes. Neutrophils are the primary 
major defence cell mobilised during an immune response against bacterial pathogens 
within the periodontal tissues and they comprise 50% of the inflammatory cell 
infiltrate within the junctional epithelium and 90% of the infiltrate within gingival 
extracellular fluid (Kowashi et al. 1980). Neutrophils are generated in the bone 
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marrow at a rate of 10
11
 cells per day but this can increase tenfold during infection 
(Cannistra and Griffin 1988). 
Under normal physiological conditions neutrophils flow in mid-stream within the 
capillaries, however during an inflammatory episode they are the first cells to be 
recruited to sites of infection or injury. Recruitment is initiated by expressed selectin 
and integrin receptors on vascular endothelium in response to chemokines secreted 
by inflamed tissues such as interleukin-8 (IL-8), which bind to chemokine receptors 
on the surface of the cell (Rollins 1997). The neutrophils follow what is known as 
the leukocyte migratory cascade resulting in exit from the blood vessel via 
diapedesis towards the site of inflammation. Neutrophil targets include bacteria, 
fungi, viruses and virally infected cells.  
Periodontitis is driven by a diversity of bacterial pathogens, which secrete a range of 
microbe-associated molecular patterns (MAMPs) that are recognised by host cells 
through pattern recognition receptors (PRRs) present on their cell surface, the result 
of which is the production and secretion of cytokines. Some of the microbiocidal 
weaponry neutrophils are equipped with to combat invading pathogens that are 
relevant to this project are outlined below.  
 
a) Phagocytosis 
Neutrophils are involved in the killing and removal of bacterial pathogens by 
phagocytosis. This is achieved through binding by two different receptor classes, Fcγ 
receptors (FcγR) and complement receptors (Witko-Sarsat 2000). Opsonised bacteria 
i.e. those coated in antibody, bind to FcγRII which aggregate on the cell surface 
(Wilson et al. 1995; Baker and Wilson 1989; Wilson et al. 1989). This leads to the 
intracellular activation of Src-tyrosine kinases which trigger various signalling 
pathways that coordinate to phagocytose the bacterial particle forming a structure 
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known as a phagosome (Greenberg et al. 1996). The phagocytosed bacterium is 
destroyed by the merging of vesicles containing microbicidal molecules (such as 
proteolytic enzymes and binding proteins such as lactoferrin which are packed in 
granules formed from the Golgi apparatus) with the phagosome. The formation and 
release of Reactive Oxygen Species (ROS) also occurs within the phagosomal space 
within cell in what is commonly known as the “respiratory burst”. Figure 1.2 shows 
an illustration of the different aspects of phagocytosis to combat Staphylococcus 
aureus which can colonise the oral cavity and cause infection. 
 
b)  Degranulation 
Neutrophils contain many hydrolytic enzymes and antimicrobial peptides (AMPs) 
capable of digesting pathogens and their products via non-oxidative pathways. These 
are stored within specialised compartments known as granules within the cytosol and 
there are three types: specific and gelatinase, which contain lactoferrin, 
metalloproteinases and lysozyme, and azurophilic which contain myeloperoxidase 
(MPO), a haem containing protein which catalyses the formation of hypochlorous 
acid from hydrogen peroxide (Farschou et al. 2003). 
 
c) Reactive oxygen Species (ROS) generation via NADPH-oxidase 
The reduction of molecular oxygen to water results in the large free energy release 
that can give rise to Free Radicals (FR) and other ROS. These molecules are 
powerful oxidizing agents formed endogenously as bi-products in metabolism and as 
a form of defence against invading pathogens (Dröge 2002). The number of 
electrons oxygen is reduced by determines which species is formed such as 
superoxide (O2
-
), hydroxyl radicals (
.
OH), hydrogen peroxide (H2O2) and 
hypochlorous acid (HOCl) (Battino et al. 1999). The importance of the oxidative 
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burst in immune defence is evident in people with severe impairments in this 
pathway, for example sufferers of chronic granulomatous disease, a hereditary 
condition in which defects in the NADPH-oxidase enzyme system result in the 
inability to generate ROS, leave the individual vulnerable to recurrent bouts of 
severe infections (Curnutte 1993). 
Superoxide production in neutrophils is mediated by the NADPH oxidase system 
located on the plasma membrane as well as on the phagosome membrane. This 
system which is composed of cytosolic and membrane subunits, generates ROS/FRs 
at the expense of NADPH. ROS formation is stimulated by the binding to antigens 
such as bacterial products, cytokines and other immune factors such as opsonised 
particles (Chapple and Matthews 2007) to membrane receptors.  
 
d) Neutrophil extracellular traps  
Neutrophil extracellular traps (NETs) are stand-like extrusions composed of 
chromatin complexed with histones and granule proteins that are released by 
neutrophils into the extracellular space as an active and terminal defence mechanism 
to immobilise pathogens (Brinkmann et al. 2004; Fuchs et al. 2007; Urban et al. 
2009). The process of NET formation is not yet fully understood, however activation 
has been shown to require ROS production through NADPH oxidase, MPO (Metzler 
et al. 2011) and HOCl (Palmer et al. 2012). NET formation is a precedent to 
apoptosis but is thought to be a controlled distinct cell death programme deployed by 
neutrophils to limit the spread of infection within the host (Fuchs et al. 2007).  
 
e) Other roles of neutrophils in the host immune response 
Neutrophils possess pattern recognition receptors (PRRs) and the most widely 
known and studied are Toll-like receptors (TLRs) which are responsible for 
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detecting pathogen-derived compounds such as lipopolysaccharide (LPS), an 
intergral component of the outer membrane of Gram negative bacteria (Erridge et al. 
2002). In particular, TLR4 and TLR2 can be stimulated by bacteria and their 
products, including F. nucleatum (Wakelin et al. 2006; Kikkert et al. 2007). Upon 
binding, downstream signalling pathways are activated such as the NF-κB pathway, 
which results in the transcription of genes involved in the pro-inflammatory 
response, induction of the respiratory burst and the production of cytokines including 
IL-6, TNFα and IL-8 although at a much lower concentration that those released by 
monocytes (Cassatella 1995; Sheikhi et al. 2000).  
Neutrophils are able to recruit other cell types including those that form part of the 
adaptive immune system. Dendritic cells and natural killer cells can be activated by 
neutrophils (Peters et al. 2008; Constantini et al. 2011). Neutrophils also express 
several T cell chemoattractants (Scapini et al. 2000) and B cell development and 
maturation factors (Scapini et al 2008).  
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Figure 1.2. Phagocytosis by the neutrophil in response to bacterial infection. The 
phagosome forms when the neutrophil is activated through the engulfment of 
bacteria such as S. aureus, a common oral pathogen. There are a number of 
microcidal components to the phagosome that collectively kill the invading organism 
(Thwaites and Gant 2011). 
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1.4  Neutrophils and the pathology of chronic inflammation 
 
While neutrophils are essential for host defence, they are also involved in the 
pathology of various inflammatory conditions. Elevated ROS production is 
implicated in a number of inflammatory disorders including rheumatoid arthiritis and 
periodontal diseases (Chapple 1997; Araujo et al. 1998). ROS can oxidise a number 
of structurally important host macromolecules when balancing its unpaired 
electronic state which can include proteins, lipids and carbohydrate resulting in 
irreversible cellular damage (Gutteridge et al. 1981; Halliwell 1994). Neutrophils are 
a rich source of ROS and in the absence of sufficient anti-oxidants within the 
periodontal tissues can lead to tissue damage (Waddington et al. 2000). Tissue 
damage occurs when neutrophil ROS are released extracellularly to such an extent 
that host antioxidants in the immediate vicinity are overwhelmed. Host tissue 
damage may arise due to premature neutrophil activation during migration, 
extracellular release of microbicidal products (e.g. elastase and ROS) during the 
killing of some microbes, or failure to resolve acute inflammatory responses (Smith 
1994). There is also evidence that the production of ROS by phagocytic cells can 
activate osteoclasts, one of the major subtypes of cells found in bone involved in 
bone resorption (Hall et al. 1995), via FOX-O and WNT signalling pathways (Galli 
et al. 2012). The cytokines that are produced by host cells in response to the 
invading microorganisms can act alone or together stimulating inflammatory 
responses such as bone resorption and collagen destruction.  
The regulation of adipokines is an essential part of inflammatory responses and 
immune functioning (Graves 2008).  The imbalance of ROS and the antioxidant 
defence systems designed to minimise cellular damage is thought to be responsible 
for a significant component of non-resolving inflammation.  
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Chronic inflammatory conditions such as periodontitis are associated with increased 
oxidative stress, with neutrophil-mediated oxidant injury playing a major role 
(Chapple and Matthews 2007; Morel et al. 1991; Noguera et al. 2001). Peripheral 
blood neutrophils from periodontitis sufferers have been shown to generate 
significantly higher levels of ROS at baseline (no priming or stimulus) and also after 
in vitro FcγR stimulation compared with gender and age-matched healthy controls 
(Matthews et al. 2007a; Matthews et al. 2007b). The hyper-responsive neutrophil 
phenotype in chronic periodontitis could be an innate property of the neutrophils 
(hyperactivity) or involve sensitising or “priming” by cytokines or bacterial 
components (hyper-reactivity) (Matthews et al. 2007a). Priming of a cell increases 
its ability to respond to a second activating stimulus with enhanced functions 
including adhesion and the production of ROS and/or cytokine release (Gustafsson et 
al. 1997; Dias et al. 2011). Signal transduction processes are involved in neutrophil 
priming and involve calcium dependent and independent pathways (Thelen et al. 
1993). A study by Matthews et al. (2007b) showed that non-surgical periodontal 
therapeutic intervention in patients with chronic periodontitis resulted in a reduction 
but not a complete removal of the hyper-reactive neutrophil phenotype with elevated 
extracellular ROS release remaining in patients versus controls. This suggests the 
role of peripheral priming of neutrophils may underlie the hyper-reactive neutrophil 
phenotype exhibited by patients with chronic periodontitis, but the neutrophil 
hyperactivity (ROS release in the absence of a stimulus) may remain, independent of 
priming.  
Neutrophils can be primed by agents including TNF-α and LPS, which result in a 
dramatic increase in the response of the cells to activating agents both in vitro and in 
vivo (Condliffe et al. 1998). Neutrophils can be quiescent, primed or active. When 
primed there is not an overt increase in oxidase activity, rather the potential to 
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generate a greater oxidative response exists when the cells are provoked with the 
appropriate stimulus (Hallett et al. 1995). The increase in oxidative response can 
lead to “oxidative stress” which is “an imbalance between oxidants and antioxidants 
in favour of the oxidants, leading to a disruption in redox signalling and control 
and/or molecular demise” (Sies and Jones 2007). Oxidative stress is implicated in 
chronic periodontitis through neutrophil hyperactivity as a constitutional element; 
however peripheral priming of neutrophils by endogenous and exogenous factors 
may also have a significant part to play. Increased production of ROS has also been 
shown in peripheral neutrophils from patients with periodontitis by other groups 
(Asman 1988; Gustafsson and Asman 1996). 
 
1.5  Obesity and inflammation 
 
Obesity is defined as a body mass index (BMI) of more than 30 kg/m
2
. It is a major 
public health problem prevalent in more than 30% of the US adult population (Flegal 
et al. 2010) and this is expected to rise. In obese individuals adipose tissue can 
constitute up to 50% of body mass. Over nutrition and increasingly sedentary 
lifestyles are the major causes of obesity. Increasing evidence links obesity to a low 
grade chronic inflammatory state (Hotamisligil 2006; Shoelson et al. 2006) which 
contributes to obesity-related diseases. The inflammatory state induced by metabolic 
surplus differs from “classical” inflammation which reflects the body’s response to 
infection or injury (redness, swelling, pain and loss of function) (Hotamisligil 2006).  
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1.6  Adipose tissue as an endocrine organ for cytokines 
 
Adipose tissue, which contains the fat storing cells of the body, has been shown to 
function as an endocrine organ that can secrete numerous factors that, with excessive 
adiposity, can cause disease through dysregulated immune responses (Ouchi et al. 
2011).  These factors are referred to as adipose-specfic cytokines or adipokines 
(Ouchi et al. 2003) and their expression in the body can vary depending on the site 
of adipose tissue deposition, in particular subcutaneous and visceral fat, which 
produce unique profiles of adipokines (Fried et al. 1998; Samaras et al. 2010). 
Adipokines are soluble proteins that bind receptors on target cells and initiate 
intracellular signalling cascades resulting in phenotypic changes to the cell through 
altered gene expression and regulation. They are effective at low concentrations and 
usually act on cellular receptors expressed by tissues within the surrounding 
environment of the cells they are produced by. They have a fundamental role in 
inflammatory disorders including periodontal disease (Hughes 1995). Adipokines, 
like other cytokines, are able to influence the secretion of other adipokines in 
networks, for example, IL-1β and TNFα can act synergistically in stimulating IL-6 
secretion by human gingival fibroblasts (Kent et al. 1998). The accumulation of 
neutrophils within the tissues of periodontitis patients is associated with upregulated 
adipokine levels including IL-8 and TNFα (Liu et al. 2001). 
Other cell types within adipose tissue include lymphocytes, macrophages and 
fibroblasts, the proportions of which can change with increasing adipocity. Adipose 
tissue is normally populated by 5-10% macrophages, but weight gain as a result of 
over nutrition can result in an increase in macrophage infiltration in adipose tissue of 
up to 60% (Weisberg et al. 2003). Conversely sustained weight loss in obese 
individuals is accompanied by a reduction in the number of adipose macrophages 
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and also concentrations of pro-inflammatory cytokines (Cancello et al. 2005) such as 
TNFα and IL-6 (Kern et al. 1995; Ziccadi et al. 2002). Table 1.1 lists the sources and 
characteristics of well-known adipokines.  
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Table 1.1. Characteristics of well-known adipokines. ANGPTL2, angiopoietin-like 
protein 2; CCL2, CC-chemokine ligand 2; CXCL5, CXC-chemokine ligand 5; IL, 
interleukin; JAK, Janus kinase; NAMPT, nicotinamide phosphoribosyltransferase; 
RBP4, retinol-binding protein 4; SFRP5, secreted frizzled-related protein 5; STAT, 
signal transducer and activator of transcription; TNF, tumour necrosis factor (Ouchi 
et al. 2011) 
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1.7  Effect of adipokines on ROS activity   
 
Many studies have reported on the effects of adipokines on ROS generation in 
neutrophils and a few examples are given here. Resistin has been shown to decrease 
the activation of the oxidative burst in neutrophils from healthy subjects (Cohen et 
al. 2008). Leptin can stimulate cells of the immune system and has been shown to 
directly stimulate neutrophils neutrophils at concentrations of up to 1000 ng/ml 
(Caldefie-Chezet et al. 2001). Jiang et al. (2011) showed that adiponectin can 
suppress the expression of NADPH oxidase in cultured vascular smooth muscle 
cells.  
 
1.8  Periodontitis and obesity 
 
Many studies have suggested that obesity is associated with oral diseases, second 
only to smoking as the strongest risk factor for periodontal tissue destruction 
(Nishida et al. 2005). The link between obesity and periodontitis disease was first 
shown by Perlstein et al. using a ligature-induced periodontitis in obese Zucker rats, 
where it was shown that bone resorption and periodontal inflammation were more 
severe in the obese cohort (Perlstein and Bissada 1977). Many epidemiological 
studies have demonstrated an association between obesity and periodontitis in 
humans (Saito et al. 1998; Saito et al. 2001; Wood et al. 2003; Saito et al. 2005) and 
also the reverse indication, that maintaining a normal weight by regular exercise is 
associated with lower periodontitis prevalence (Wakai et al. 1999; Karjalainen et al. 
2002; Merchant et al. 2003).  
The underlying biological mechanisms for the association between obesity and 
periodontitis are not known. Oxidative stress is thought to link periodontitis and 
metabolic syndrome (MetS), which encompasses a range of metabolic disorders 
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including high blood pressure and impaired glucose regulation (Eckel et al. 2005) 
and its root cause is linked to a chronic pro-inflammatory state. The bidirectional 
link between periodontitis and MetS is illustrated in figure 1.3.  
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Figure 1.3. Potential role of oxidative stress linking periodontitis and metabolic 
syndrome (MetS) (Bullon et al. 2009). An individual suffering from periodontitis 
could be at risk of developing insulin resistance; an increase in ROS production has 
been shown to precede insulin resistance (Matsuzawa-Nagata et al. 2008). In 
contrast, an individual suffering from MetS or its components (obesity for example) 
and therefore exhibiting diminished anti-oxidant capacity of the periodontal tissues 
facilitating the pathology of infectious bacterial agents as a result of impaired 
immune responses (Bullon et al. 2009). 
RAGE: receptor for advanced glycation end products. The presence of high RAGE 
expression in periodontal tissues supports their sensitivity to products derived from 
oxidative damage (Katz et al. 2005). 
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1.9   Methods of studying neutrophil activity 
 
The focus of this project is the regulation of ROS and NETs by neutrophils, therefore 
selecting the most appropriate method to study them is important. Neutrophils are 
one of the shortest-lived cells in the body (5.4 days) (Pillay et al. 2010) abundant in 
the circulation and are therefore readily accessible for experimental investigation. 
Neutrophil cell lines that are cultured in vitro do not reflect the complex biological 
reality in tissues or the circulation. In vivo studies of neutrophils, such as those done 
in mice differ in important aspects from the human equivalents, for example the 
numbers of neutrophils in the circulation differ in mice and humans 30% versus 70% 
respectively (Amulic et al. 2012). The best available methods to study these cells is 
through ex vivo work, which involves isolating the cells from the peripheral blood of 
volunteers and their subsequent use in assays that measure their activity when 
exposed to appropriate stimuli.  
The major activities of neutrophils involved in immune responses and linked to 
inflammation are ROS generation, protease release and NET formation. There are 
several methods of studying ROS activity and these are highlighted below: 
 
i) Nitroblue tetrazolium (NBT) is a substrate for oxidases and ROS activity can be 
measured spectrophotmetrically by measuring the reduction of NBT (a yellow 
soluble substance) to formazan (a blue insoluble substance) (Seymour et al. 
1986).  
ii) Flow cytometry is a method for characterising single cells via labelling them 
with fluorescent dyes. ROS activity can be measured using this technique by 
evaluating 2,7-dichlorofluorescin (DCF), the fluorescent oxidative product of 
neutrophils upon stimulation with PMA (Battino et al. 1999). 
20 
 
iii) ROS can be detected spectrophotometrically at 550 nm by following 
Cytochrome C reduction. 
iv) ROS produced upon stimulation can oxidise the cyclic hydrazine 5-amino-2,3-
dihydo-1,4phthalazinedione (luminol) to 3-aminopthalate, which is accompanied 
by the emission of light as the anion relaxes from an excited to a ground state 
(Allen and Loose 1976). Luminol-dependent chemiluminescence assesses total 
ROS generation (intra and extracellular) as luminol has the ability to cross 
cellular membranes. Luminol is the most sensitive chemiluminescent substrate 
for detecting ROS generation by neutrophils in the laboratory environment 
(Kopprasch et al. 2003) and was therefore the chosen method in this study. 
 
1.10 Methods of studying NET activity  
 
NETs can be studied quantitatively and qualitatively. NET imaging techniques 
include Immunofluorescence microscopy, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM) and live cell imaging (Brinkmann et al. 
2010). The images generated provide a backdrop to quantitative analysis which 
involves fluorometric measurement of the NET DNA labelled with a nucleic acid 
stain, such as sytox green. 
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1.11 Project aims 
 
The aims of this project were:  
- To determine if adipokines at physiological levels reflective of lean and obese 
individuals are able to prime neutrophils sufficiently to generate differential 
ROS upon exposure to a second periodontally relevant bacterial stimulus.  
- To measure the effect of different adipokine concentrations that have  previously 
shown to positively prime neutrophils for enhanced ROS generation following 
their exposure to periodontally relevant bacterial stimuli. 
- To determine if NET production by peripheral blood neutrophils is affected by 
neutrophil pre-incubation with lean or obese concentrations of adipokines. 
- To compare the responses of neutrophils to activation of TLR or FcγRII 
receptors and to direct activation of PKC by PMA. 
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2. Methods 
2.1 Adipokine concentrations utilised 
 
A literature review of research publications that measured lean and obese 
concentrations of adipokines used in this project was performed. Key words were 
entered into search engines such as “Sciencedirect” and “PubMed” to find relevant 
studies that use or measure the adipokine concentrations of obese and lean 
individuals. From these studies the most appropriate concentrations were chosen 
based on the experimental technique used by a particular study and the medium in 
which the concentrations were taken, for example blood serum or plasma.  
 
2.2 Blood collection 
 
Healthy male volunteers were recruited for this project from staff and students of the 
Birmingham Dental Hospital. All had a BMI within the healthy range (19-24 kg/m
2
) 
measured on the day of blood collection. Waist-hip ratio measurements were also 
taken. All were non-smokers, non-diabetic and were not taking anti-inflammatory 
drugs. Approximately 25ml of blood was collected into Vacutainer
TM
 (Greiner Bio-
One Ltd, Stonehouse, UK) lithium heparin (17 IU/ml) tubes. Upon collection the 
tubes were inverted 8-10 times to prevent blood clotting. Approximately 20 minutes 
after collection the blood was processed for neutrophil isolation. Ethical approval 
was provided by the University of Birmingham (ERN_10-0518) and donors gave 
their informed consent. Table 2.1 shows the health characteristics of the volunteers. 
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Assay Number of 
volunteers 
Age (y) BMI (kg/m2) Waist to 
hip ratio 
ROS assays with TNFa 
and IL-6  
10 23.6±0.23 22.06±0.22 0.87±0.005 
ROS assays with priming 
concentrations of 
adipokines 
5 23.2±0.52 21.00±0.32 0.86±0.005 
ROS assays with priming 
concentrations of TNFa 
and IL-6 in combination  
5 23.4±0.46 21.4±0.39 0.86±0.005 
ROS assays with 
adipokines resistin, leptin, 
adiponectin, GM-CSF and 
IL-8  
10 23.4±0.30 21.2±0.19 0.85±0.004 
 
Table 2.1 Health characteristics of the volunteers. Waist to hip ratio signifiers: 
excellent <0.85; good 0.85-0.90; average 0.90-0.95; high 0.95-1.00; extreme >1.00. 
All volunteers were between average and excellent. BMI signifiers: 20-25 healthy, 
25-30 overweight; 30-35 obese; 30-35 severely obese; >40 morbidly obese. All 
volunteers were within the healthy range. 
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2.3 Neutrophil isolation 
 
Neutrophils were isolated from blood samples using percoll (GE Healthcare), a 
1,130 g/ml colloidal silica suspension coated with polyvinylpyrolidone (PVP) 
(Pertoft et al. 1978). Two discontinuous gradients were used for neutrophil isolation. 
Densities of 1.079 and 1.098 were prepared as shown in table 2.2. 
8ml of 1.098 density was layered under 8ml of 1.079 density percoll in a centrifuge 
tube. 8-9 ml of blood was then layered at the top of the tube. The cells were 
centrifuged for 8 minutes at 150 g (RCF), followed by 10 minutes at 1200 g. 
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Density 1.079 1.098 
Percoll 19.708 ml 24.823 ml 
Water 11.792 ml 6.677 ml 
NaCl (1.5 M) 3.5 ml 3.5 ml 
 
 
Table 2.2 Components of the percoll gradients. 
 
 
 
 
 
 
Figure 2.1 Photograph showing separation of the blood by differential percoll 
gradients. 
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The neutrophil layer within the supernatant was removed by gentle aspiration using a 
Pasteur pipette and added to another centrifuge tube containing 30 ml of buffer 
[0.83% NH4Cl containing 1% KHCO3, 0.04% Na2 ethylendiamine tetraacetic acid 
(EDTA), 2h2O and 0.25% bovine serum albumin (BSA)]  for erythrocyte lysis. A 
final volume of 50 ml with additional lysis buffer was achieved. The tubes were 
gently inverted several times and left at room temperature for 10 minutes to allow for 
erythrocyte lysis. The cells in suspension were then pelleted at 350 g for 6 minutes. 
The supernatant was discarded and the pellet was resuspended in 3 ml lysis buffer. 
After a repeat centrifugation step, the cells were washed with 3 ml PBS, centrifuged 
again, the supernatant was removed and the cells were made up to a final volume of 
~2-3 ml PBS. 
The cells were counted using a haemocytometer (figure 2.2) which included 
duplicate total cell and trypan dye exclusion counts (which were diluted 1:2). 
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Figure 2.2  A haemocytometer grid. The red squares were the designated regions for 
counting neutrophils. This was scaled up using the equation described.  
 
1cm
3
 = 10mm
3
. The small squares in red were counted. Each small square within the 
top right hand grid has a volume: 0.2 x 0.2 (width) x 0.1 (depth) = 0.004 mm
3
.  
Therefore the cells within the 9 squares were counted and the number of cells per ml 
was calculated as follows: 
- Cell count /9 x 25 = no. of cells in the entire grid. 
- No. of cells in the grid x 104 = no. of cells per ml. 
This was repeated twice as were trypan blue counts (10 μl of cell suspension in 10 μl 
of trypan blue). 
For both NET and ROS assays, 1 x10
5
 cells/ml was required for each well (final 
volume 200 μl) and were diluted in gPBS accordingly.  
For the NET visualisation assay the cells were made up to the same volume using 
RPMI (Biosera RM-R1640/500) enriched with L-glutamine. 
 
 
 
1 cm 
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2.4 Adipokine preparation 
 
All adipokines were purchased from Sigma-Aldrich (Dorset, UK). The 
concentrations representative of lean and obese individuals for each is shown in table 
2.1. The adipokines were diluted in PBS with 10% BSA and stored at -20 ºC prior to 
use. 
 
2.5 Stimulus preparation 
 
2.5.1 Staphylococcus aureus 
 
S. aureus NCTC 6571, obtained from Fisher Scientific, was stored at -40 ºC in 
cryopreservative on beads (Prolab PL160). A single bead was retrieved and used to 
inoculate a mannitol salt agar plate and left to incubate at 37 ºC for 24 hours. The 
growth of the bacteria discolours the agar from a red to a yellow appearance. Several 
colonies were picked from the agar plate to inoculate 500 ml sterile tryptone soya 
broth which was cultured for 24 hours (standing) at 30 ºC. The following steps 
outline the process of S. aureus opsonisation 
 
1. Calculation of concentration of S. aureus 
To approximate the number of bacteria from the broth culture, six 1ml serial 
dilutions (1:10) were made. 100 μl from the 5th and 6th dilution were inoculated onto 
Mannitol Salt Agar plates and incubated at 37 ºC for 24 hours. Optical density (OD) 
measurements were also taken of the 5
th
 and 6
th
 dilution. The following day the 
numbers of colonies were counted, this was scaled back to the original broth to give 
the approximate concentration of bacterial cells in the original 500 ml of broth.  
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2. Harvesting of bacteria 
The bacteria grown in broth were pelleted in 10 x 50 ml tubes for 5 minutes at 6,000 
rpm at 4 ºC in a Harrier 18/80 centrifuge (swing-out rotor). The supernatant was 
discarded and the pellets were re-suspended in 20 ml PBS and mixed by vortexing. 
The 20 ml PBS suspensions were pooled into 4 x 50 ml tubes and the washing step 
was repeated. After discarding the supernantant the pellets were re-suspended in PBS 
and pooled into 2 x 50 ml tubes and washed once more. The supernatant was 
discarded and the pellets were used for fixation. 
 
3. Fixation 
The harvested cells were re-suspended in 20 ml formyl buffered saline (strong 
formalin diluted 1:10 and 8.5 g NaCl per litre) for 1 hour at room temperature. The 
fixative was removed by centrifugation (same settings as during harvesting) and 
washed three times with PBS. The pellets were re-suspended in a final volume of 5 
ml PBS and stored at 4 ºC. 
 
4.  Opsonisation with IgG 
The isolated and fixed S. aureus was incubated at 80 °C for 20 minutes and allowed 
to cool. Vigam (Human IgG) 5 g/100 ml liquid (BPL) was added at 33 μl per 1 x 109 
bacterial cells. The cells were left to incubate with a rotation device at room 
temperature overnight. The cells were then pelleted at 6,000 rpm for 10 minutes at 4 
ºC, washed twice with PBS and re-suspended in a final volume of 5 ml PBS. The 
cells were diluted 1:100 with PBS and divided into aliquots of 500 μl and stored at -
20 ºC prior to use. The number of bacteria required per well in all assays is 3 x 10
7
 
(300 bacteria per neutrophil) (Bergström and Asman 1993).  
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2.5.2 Fusobacterium nucleatum 
F. nucleatum (ATCC 10953) was supplied by LGC Standards in freeze-dried format. 
250 µl Brain heart infusion broth with 10% serum (Oxoid BO0129E) was added to 
the freeze-dried bacterial powder and re-suspended in a sterile test tube. A further 3 
ml of broth was added. 100 µl of the suspension was streaked onto horse blood agar 
plates with 10% serum (Oxoid PB0114) and incubated for 24-48 hours in an 
anaerobic chamber at 37 ºC. A third plate was inoculated and left under aerobic 
conditions at the same temperature to test for purity.   
A single colony was inoculated in the brain heart infusion broth and incubated 
anaerobically for 24-48 hours, after which OD measurements were taken and 1 ml of 
the bacterial suspension was diluted further in 1 litre of broth and streaked across 
new agar plates for bacterial quantification. The broth culture was pelleted and 
washed in PBS 3 x before re-suspending in a final volume of 20 ml PBS. The 
bacteria were heat killed by incubating at 80 ºC for 20 minutes. The number of 
bacteria present on the agar plates was used to approximate the number of bacteria 
present in the broth culture. Approximately 100 bacteria are required per neutrophil. 
The bacteria were stored at -20 ºC prior to use. 
 
2.5.3 Phorbol 12-myristate 13-acetate preparation 
PMA was supplied by Sigma (P8139). It was dissolved in 1 ml 20 mM DMSO 
before being diluted in PBS and stored at -20 ºC prior to use. A concentration of 0.1 
µM was used.   
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2.6 ROS assays 
White microwells (Microlite 2, VWR, Lutterworth, UK, 8 wells/strip for 96 well 
plate format) were pre-blocked overnight using filter sterilised 1% BSA (Sigma 
A4503) in PBS. 200 μl was added to each well and stored overnight at 4 ºC. The 
plate was then washed three times with PBS using a microplate washer (BioTek 
ELx50). 
Different concentrations of adipokines were added to the cells in combination with 
each stimulus (F. nucleatum, opsonised S. aureus, PMA or negative control) as 
shown in table 2.3. 
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Adipokine Lean concentration 
Obese 
concentration Priming concentration 
TNFα 2 pg/ml 4 pg/ml 3 ng /ml and 5 ng /ml 
IL-6 0.5 pg/ml 1.5 pg/ml 100 ng/ml and 1000 ng/ml 
Adiponectin 13.3 μg/ml 8.6 μg/ml 10 μg/ml 
Leptin 6.4 ng/ml 23.45 ng/ml 250 ng/ml 
Resistin 12.8 ng/ml 33 ng/ml 30 ng/ml 
IL-8 (positive 
control)   10 ng/ml 
GM-CSF (positive 
control)     100 ng/ml 
 
Table 2.3 Lean and obese concentrations and priming concentrations of adipokines 
used in this study. 
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All samples were assayed in triplicate (representative of one individual). Each 
microwell had a final volume of 200 μl. The cells and luminol were loaded into the 
microwells and luminescence was recorded using a Berthold microplate luminometer 
(LB96v) and Winglow software for 30 minutes at 37 ºC. Adipokines and PBS 
supplemented with glucose and cations (1.8 g glucose, 0.15 g CaCl2 and 1.5 g 
MgCl2) (gPBS) as a control, were then added and luminescence was recorded. A 
further 30 minutes following this, the test stimulus (bacteria or PMA) was added or 
gPBS for controls and luminescence was recorded for a further 60 minutes. 
Triplicate measurements were recorded per condition per individual. Table 2.4 
shows the components and volumes of wells for all ROS assays in this project. 
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Luminol 
(µl) 
Adipokine 
(µl) 
Stimulus 
(FN/PMA/SA) 
(µl) 
Neutrophils 
diluted in in 
gPBS (µl) 
Additional 
gPBS 
Control  30 0 0 100 
 
70 
Adipokine only 30 10 0 100 
 
60 
Stimulus only 30 0 25 100 
 
45 
Adipokine and 
stimulus 30 10 25 100 
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Table 2.4 Components of all the ROS assays. Total volume in each well was 200 µl. 
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2.7 Control ROS assays 
2.7.1 Cell free ROS assay  
To ensure no background luminescence activity was occurring an assay was 
completed with all components of the ROS assay but excluding neutrophils. After 
washing pre-blocked microwells all components of the ROS assay (priming agents, 
stimuli, luminol) as displayed in table 2.5 were added with the exception of 
neutrophils and placed into the luminometer. Luminescence was recorded over a 12 
second  period, after 2 seconds 30 µl 1% H2O2 diluted in water and 0.0008 Units/µl 
of horseradish peroxidase was used to generate luminescence activity by oxidation of 
luminol. Measurements were recorded using the Berthold Microplate Luminometer 
LB 96V and Winglow software. 
 
2.7.2 Cell metabolic activity assay 
To estimate the metabolic activity of neutrophils within the ROS assays the cellular 
ATP content was measured using Cell Titre Glo (Promega), a reagent used to 
determine the quantity of ATP within a cell by use of a luminescent substrate. 
Neutrophils were isolated as described previously and the same protocol for the ROS 
assay was adopted (adipokines, neutrophils and gPBS) however no stimulus 
(bacteria/PMA) or luminol was added. The plate was measured for luminescence 
activity using the same programme for the same length of time as the ROS assay. At 
three time points (0 minutes, 30 minutes and 80 minutes) 80 µl CellTitre-Glo 
luminescent substrate (Promega) was added. This substrate indicates the number of 
viable cells in culture based on quantification of the ATP present, which signals the 
presence of metabolically active cells.  
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2.8 NET assays 
2.8.1 Micrococcal nuclease (MNase) assay 
 
96 well micro plates were pre-blocked with 200 μl filter sterilised 1% BSA in PBS at 
4 ºC overnight. After washing the plate, neutrophils were suspended in 100 μl with 
RPMI to give a concentration of 1 x 10
6
 cells/ml. Neutrophils (diluted in RPMI) and 
respective adipokines or RPMI were added and left to incubate at 37°C with 5% CO2 
for 30 minutes. Stimulus was then added and the plate was left to incubate for a 
further 2 hours. 15 μl of 14.3 units/ml MNase (Worthington LS004797) diluted 
1:100 with PBS was added and the plate was incubated at room temperature for 10 
minutes. The microplate was centrifuged at 1800 RCF for 10 minutes. 150 μl of the 
supernatant from each well was placed into a new black 96 well microplate. 15 μl of 
10 μM SYTOX green (Invitrogen S7020) diluted 1/500 in RPMI was added to each 
well. DNA fluorescence was read 5 times using a Berthold Twinkle LB970 
fluorometer with excitation at 485 nm and emission at 525 nm. Data was obtained 
using Mikrowin software. Table 2.5 shows the template for the MNase assay. 
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Cells in 
RPMI (µl) 
Cytokine 
(µll) 
Stimulus 
(FN/PMA/SA) 
(µl) 
MNase 
(µl) Sytox (µl) 
Control  170 0 0 15 15 
Adipokine only 160 10 0 15 15 
Stimulus only 145 0 25 15 15 
Adipokine and 
stimulus 135 10 25 15 15 
 
Table 2.5 Components of the MNase assay. 
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2.8.2 Control MNase assay  
To demonstrate that the fluorescence activity was recorded from NET-derived DNA 
an assay was completed with all components of the NET assay except neutrophils. 
Various concentrations of DNA were added to show that DNA can be detected and 
quantified in a concentration-dependent manner. Calf thymus DNA was supplied by 
Sigma (89370) and diluted in molecular biology quality water to 0.5 µg. This was 
further diluted 1:2 down to 0.03 µg. 10 µl of each dilution was added. The total 
volume per well was made up to 200 µl with RPMI. DNA fluorescence was read five 
times using a Berthold Twinkle LB970 fluorometer as previously described.      
 
2.8.3 NET visualisation assay 
 
Costar 24-well plates were blocked with 500 μl PBS with 1% BSA and incubated at 
4 ºC overnight. The liquid was removed by vacuum aspiration and the cells (1 x 
10
5/ml, 200 μl/well) suspended in RPMI were added. The plate was incubated in a 
37 ºC at 5% CO2 enriched environment for 30 minutes, after which adipokine (20 µl) 
was added and the cells were incubated for a further 30 minutes. Stimulus (25 µl) 
and further RPMI (50 µl) was then added and the plate was incubated at 37 ºC for 2 
hours.  
After the incubation 25 μl of 100 nM SYTOX green (Invitrogen S7020) diluted in 
RPMI was added to each well. The plate was imaged using a fluorescence 
microscope (Nikon Eclipse TE300, Surrey, UK) using a x20 objective lens and 
images captured by digital camera (Nikon CoolPix 450, Surrey, UK). 
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3. Results 
3.1 Adipokine concentrations 
 
Table 3.1 shows the different physiological adipokine concentrations found in 
human subjects. Highlighted in green is the lean or obese concentrations used in this 
project, in red are the priming concentrations also used. Table 2.3 gives a refined 
summary of the adipokine concentrations.   
Many studies demonstrate the potential for GM-CSF and IL-8 to enhance the 
respiratory burst in neutrophils when exposed to the appropriate secondary stimuli 
(Nathan 1989; Weisbart et al. 1985). 
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Table 3.1 Adipokine concentrations identified through a literature search. Highlighted in 
green are the concentrations reflective of lean and obese people which were used. Red 
highlights concentrations shown to positively prime/activate neutrophils. 
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3.2 Control assays 
3.2.1 Cell free ROS assay 
 
The cell free ROS assay demonstrated that in the absence of neutrophils there was no 
background oxidative activity arising from any of the other assay components. The 
addition of hydrogen peroxide is measured as an increase in luminescence and 
demonstrated that none of the components block the luminescent signal. The results 
of the cell free assay are shown in Figure 3.1 a-e. The addition of all components in 
all combinations did not generate any luminescence and therefore no NADPH 
oxidase independent ROS. When hydrogen peroxide was added there was a sharp 
increase in luminescence that fell back down to baseline seconds after its addition. 
Hydrogen peroxide is a highly reactive oxygen species and a powerful oxidising 
agent. When added to the wells the horseradish peroxidase catalyses the reaction of 
the hydrogen peroxide with the luminol which results in energy release in the form 
of light. The hydrogen peroxide is then decomposed to form oxygen and water.  
Figure 3.1 shows that the various adipokines and positive controls used in this 
project do not prevent luminescence from being detected or inhibit peak signals over 
the blank (control). The data is representative of one individual with repeats in 
triplicate for each condition. 
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Figure 3.1 a) Cell free ROS testing luminescent signal activity with adiponectin and 
stimuli. 
 
 
 
Figure 3.1 b) Cell free ROS testing luminescent signal activity with leptin and 
stimuli. 
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Figure 3.1 c) Cell free ROS testing luminescent signal activity with resistin and 
stimuli. 
 
 
Figure 3.1 d) Cell free ROS testing luminescent signal activity with TNFα and 
stimuli. 
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Figure 3.1 e) Cell free ROS testing luminescent signal activity with IL-6 and stimuli. 
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3.2.2 Cell metabolic assays 
Figure 3.2 shows the decay of luminescence over the time course of the cell 
metabolic assay. Cell Titer Glo was added at 0, 30 or 80 minutes.  Cells followed 
from time 0 demonstrate the same decay of ATP quantity as those with substrate 
added at 30 and 80min. This demonstrates the decreasing metabolic activity of the 
short-lived neutrophils and that the addition of the substrate did not affect the 
activity of the cells. Figures 3.3a-e shows the influence of adipokines on the cell 
metabolic activity over the 120 minute time period, which is the total duration of the 
ROS assay to show that the cells are still metabolically active.  Here little difference 
was seen for TNFa, IL-6, adiponectin or leptin. Resistin showed an altered pattern in 
cell metabolic activity, which should be further examined, however it should also be 
noted that this experiment has only be completed with one volunteer, as is therefore 
preliminary in nature.  
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Figure 3.2 Cell metabolic assay with cells in gPBS at various time points that 
represent the addition of adipokine, and stimulus and the extent of cell metabolic 
activity after 2 hours. 
 
 
 
 
Figure 3.3 a) Cell metabolic assay with adiponectin and Cell Titer Glo added at the 
point the stimulus would be added (60 minutes) and at the end point of the assay 
(120 minutes) to show that the cells are metabolically active. 
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Figure 3.3 b) Cell metabolic assay with leptin. 
 
 
 
 
 
 
Figure 3.3 c) Cell metabolic assay with resistin. 
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Figure 3.3 d) Cell metabolic assay with TNFα. 
 
 
 
 
 
Figure 3.3 e) Cell metabolic assay with IL-6. 
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3.3 ROS assays 
3.3.1 ROS assay results with lean and obese concentrations of adipokines  
 
The data collected from the ROS assays included peak signal and area under the 
curve data (also known as integration) for the 30 minute (prior to addition of any 
adipokine), 60 minute (addition of adipokine) and 90 minute (addition of stimulus) 
time points. The peak signal gives the highest output score in relative light units 
(RLU) whereas integration provides the area under the curve between specified X-
axis time points. 
The data was analysed using Prism 5.0. Control values were subtracted from all 
other conditions, after which control adipokine values were subtracted from the 
corresponding adipokine with stimulus added. For example TNFα lean concentration 
alone was subtracted from TNFα lean concentration with PMA. The lean and obese 
peak and integration results for each adipokine were then compared graphically and 
statistically. A Wilcoxon matched-pairs signed rank test was performed on all ROS 
results. 
Figures 3.4 and 3.5 show mean ROS activity of all volunteers (n = 10) with 
adipokines and stimuli. Tables 3.2 and 3.4 provide a summary of the integration and 
peak data for ROS assays with lean versus obese adipokine concentrations and 
stimuli respectively, which are derived from figures in the supplementary data 
(figure S1-S16). Tables 3.3 and 3.5 provide summaries of the positive priming 
controls, GM-CSF and IL-8, versus stimulus alone.  
It should be noted that for both peak and integration results at the 30 minute time 
point the neutrophils are at baseline (i.e. no adipokine or stimulus present) and no 
increase in luminescence is expected. At the 60 minute time point adipokines have 
been added, and again there should not be any significant ROS generation (unless the 
50 
 
adipokines directly stimulate ROS rather than prime the neutrophils) until the 120 
minute time point, at which the stimulus has been added. Any ROS generation at 60 
minutes implies neutrophil stimulation, rather than priming, for a secondary 
stimulus. 
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Priming 
agent  
Stimulation
 
F.nucleatum Opsonised S. aureus PMA 
Time point (mins)  60’ 120’ 60’ 120’ 60’ 120’ 
TNFa - - - -   
IL-6 - - - P=0.006   
Adiponectin   - - - P=0.001 
Leptin   P= 0.01 - - - 
Resistin   - - - - 
 
Table 3.2 Summary of integration data for ROS production after priming 
concentrations (lean & obese) of adipokines and various stimuli. - Denotes no 
significant difference between lean and obese adipokine-induced ROS production;  
denotes a significant increase between of obese over lean neutrophils for the 
stimulant highlighted (obese > lean). All data were normalised by the subtraction of 
the blank and/or adipokine alone signal. 
 
 
 
 
 
 
Priming agent 
 
Stimulation Opsonised S. aureus PMA 
Time point (mins)  60’ 120’ 60’ 120’ 
GM-CSF - -  P = 0.002  P = 0.02 
IL-8 - ↓ P = 0.003 -  P = 0.01 
 
Table 3.3 Summary of integration data for ROS production after priming with 
positive controls GM-CSF and IL-8 and stimuli. - denotes no significant difference 
between lean and obese adipokine-involved ROS production;  denotes a significant 
increase between lean and obese treated neutrophils for the stimulant highlighted 
(obese > lean). ↓ denotes a significant decrease in ROS generation in priming 
concentration of adipokine compared to stimulus-only treated neutrophils (stimulus 
alone > adipokine + stimulus).  
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Priming 
agent  
Stimulati
on 
F.nucleatum Opsonised S. aureus PMA 
Time point (mins)  60’ 120’ 60’ 120’ 60’ 120’ 
TNFa - - - -   
IL-6 - - - P=0.025   
Adiponectin   - - - P= 0.002 
Leptin   - - - P= 0.00371 
Resistin   - - - ↓ P = 0.002 
 
Table 3.4 Summary of peak data for ROS production after priming concentrations 
(lean & obese) of adipokines and various stimuli. - Denotes no significant difference 
between lean and obese adipokine-induced ROS production;  Denotes a significant 
increase between lean and obese treated neutrophils for the stimulant highlighted 
(obese > lean). ↓ denotes a significant decrease in ROS generation in obese 
compared to lean treated neutrophils (lean > obese).  
 
 
 
 
 
 
Table 3.5 Summary of peak ROS production after priming with positive controls 
GM-CSF and IL-8 and stimuli. - Denotes no significant difference between 
adipokine-induced and stimulus-only ROS production. ↓ denotes a significant 
decrease in ROS generation in priming concentration of adipokine compared to 
stimulus-only treated neutrophils (stimulus alone > adipokine + stimulus).  
  
 
 
 
 
 
 
 
 
Priming agent 
 
Stimulation Opsonised S. aureus PMA 
Time point (mins)  60’ 120’ 60’ 120’ 
GM-CSF - - - - 
IL-8 - - -  P = 0.01 
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TNFα 
There were no significant differences between 2 pg/ml (lean) and 4 pg/ml (obese) 
priming concentrations of TNFα for the integration signal following a secondary 
stimulus with F. nucleatum (figure S.1-2; table 3.2). The same was true of peak data 
(figure S.3; table 3.4). When S. aureus was used as a stimulus, similarly, no signal 
differences were found for lean or obese concentrations of TNFα as a priming agent 
(figure S.2 and S.4). 
 
IL-6 
Tables 3.2 and 3.4 highlight a statistically significant difference between IL-6 obese 
concentrations (1.5 pg/ml) in enhancing ROS production over IL-6 lean 
concentrations (0.5 pg/ml) when stimulated with opsonised S. aureus from 
integration and peak data (P = 0.006 and P = 0.03 respectively) (figure S.2 and S.4).  
 
Adiponectin 
 
Adiponectin priming showed a statistically significant increase in obese (8.6 μg/ml) 
over lean (13.3 μg/ml) concentrations when stimulated with PMA for both 
integration (P = 0.001) and peak data (P = 0.002) as shown in figure S.5 and S.8 and 
tables 3.2 and 3.4. There were no significant differences between lean and obese 
concentrations of adiponectin when assessed for priming for a secondary S. aureus 
stimulation. 
 
Leptin 
 
There was no significant difference for integration data at the 120 minute time point 
with leptin with either PMA or S. aureus stimuli, however the peak data show a 
significant difference between lean (6.4 ng/ml) versus obese (23.45 ng/ml) at 120 
minutes with PMA stimulus (P = 0.004) (figure S.8). 
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Resistin 
The only statistically significant result with resistin was a decrease in peak ROS 
activity between lean (12.8 ng/ml) and obese concentrations (33 ng/ml) (P = 0.002), 
following PMA stimulation (figure S.9 and table 3.4). 
 
GM-CSF 
The integration results showed a clear increase in ROS generation when the 
neutrophils are pre-incubated with GM-CSF at both 60 minutes (pre-incubation) and 
120 minutes (addition of PMA stimulus) (P = 0.002 and 0.02 respectively) (figure 
S.6 and table 3.3) . There was no statistically significant differences in the peak data, 
which highlights the importance of analysing both peak and integration results; the 
effect of an agent on ROS activity can differ with some causing a sharp increase 
(PMA) while others causing a more pronounced long-term ROS generation (S. 
aureus). 
 
IL-8 
IL-8 shows a differential response for integration and peak results which appear 
dependent on the chosen stimuli. There were statistically significant responses at 
integration (P = 0.01) and peak (P = 0.01) over PMA stimulus alone (figures S.7 and 
S.10, tables 3.3 and 3.5). Stimulation with opsonised S. aureus gave a significantly 
lower response when the neutrophils were pre-incubated with IL-8 at integration 
(figure S.13 and table 3.3). 
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ROS with TNF and F. nucleatum stimulus
Time (minutes)
R
L
U
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
0
5000
10000
15000
gPBS
TNF  2 pg/ml
TNF  4 pg/ml
F. nucleatum
TNF  2 pg/ml + F. nucleatum
TNF  4 pg/ml + F. nucleatum
ROS assay results with lean versus obese concentrations of
TNF and IL-6 and F. nucleatum stimulus
Time (minutes)
R
L
U
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100
0
5000
10000
15000 gPBS
IL-6 0.5 pg/ml pg/ml
IL-6 0.5 pg/ml
F. nucleatum
IL-6 0.5 pg/ml + F. nucleatum
IL-6 1.5 pg/ml + F. nucleatum
ROS with IL-6 and F. nucleatum stimulus
 
 
 
Figure 3.4a and 3.4 b) ROS assay result with lean versus obese concentrations of 
TNFα and IL-6 with F. nucleatum stimulus respectively. 
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Figure 3.5 a and 3.5b ROS assay result with lean versus obese concentrations of 
TNFα and IL-6 with S. aurues stimulus. 
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Adiponectin and PMA
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Resistin and PMA
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Figure 3.6 a,b,c  ROS assay results with adiponectin, leptin, resistin, GM-CSF and 
IL-8 with PMA stimulus 
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Adiponectin and S. aureus
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Resistin and S. aureus
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Figure 3.7a, b and c. ROS assay results with adiponectin, leptin, resistin, GM-CSF 
and IL-8 with S. aureus stimulus. 
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3.3.2 ROS with priming concentrations of adipokines 
 
Figures 3.8, 3.9 and 3.10 show ROS assay results with the adipokines at “priming 
concentrations” i.e. the concentration at which the cell is affected according to the 
scientific literature. Adiponectin, resistin and leptin do not show an increase in ROS 
activity upon stimulation with PMA (figures 3.8a-c). Stimulation with S. aureus 
shows an increase for leptin and resistin over the control but not for adiponectin 
(which would be expected due to its anti-inflammatory properties) (figures 3.9 a,b 
and c). GM-CSF and IL-8 enhances the respiratory burst in all the ROS assays 
(figures 3.8 and 3.9). Priming with TNFα and IL-6 show enhanced ROS activity with 
increasing concentrations compared to stimulus alone (3.10 a-b). 
The peak and integration data were also analysed from the priming ROS assays, 
however there were no statistically significant differences at any of the three times 
points (data not shown). This is probably due to the low numbers of individuals used 
in the assays (n = 5). In some cases an aberrant result, probably due to pipetting 
errors, meant exclusion of that result. This demonstrates the importance of larger 
numbers of individuals in these experiments to normalise any outlying data and 
provide a more accurate reflection of what may be affecting neutrophil activity.   
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Resistin priming and PMA
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Figure 3.8 a,b,c ROS assay results with priming concentrations of adiponectin, leptin 
and resistin, controls GM-CSF and IL-8, and PMA stimulus. 
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Adiponectin priming and S. aureus
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Resistin priming and S. aureus
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Figure 3.9 a-c ROS assay results with priming concentrations of adiponectin, leptin 
and resistin, controls GM-CSF and IL-8, and S. aureus stimulus. 
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ROS assay of TNF  priming concentrations with S. aureus
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Figure 3.10a-b ROS assay results with priming concentrations of TNFα and IL-6 
with S. aureus stimulus. 
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3.3 NET assays 
3.3.1 Control MNase assay 
 
To control for any interference of adipokines in the NET MNase assay experiments 
were run with all components except for neutrophils. Increases in fluorescence with 
varying quantities of DNA were proportional to the increasing DNA quantity added. 
Results are shown in figures 3.11a-c and 3.12a-b, representative of two separate 
experiments. Results show that S. aureus appears to interfere with AFU readings at 
lower DNA concentrations. This is also true when S. aureus is combined with leptin 
and resistin. Data is representative of one individual with each condition performed 
in triplicate. 
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Figure 3.11a 
 
Figure 3.11b 
 
Figure 3.11c 
Figure 3.11 MNase cell free assays with adipokines and stimuli 
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Figure 3.12a 
 
Figure 3.12b 
Figure 3.12 Cell free MNase with adipokines. 
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3.3.2 MNase assay 
Tables 3.6 and 3.7 summarise the NET MNase assay. The raw data is shown in 
figures 3.13- 3.15. Wilcoxon matched-pairs signed rank test was performed on for all 
NET results. Adiponectin and leptin showed no overall significant results. 
Interestingly resistin showed a decrease in NET production when incubated with the 
neutrophils at obese concentrations over lean in the absence of any stimulus (P = 
0.02), which was unexpected as no NETs should be produced in the absence of 
stimuli, however after stimulation with PMA there was a significant increase in NET 
production at the obese concentrations over lean. Obese concentrations of TNFα 
increased NET production over lean when stimulated with S. aureus (P = 0.03). IL-6 
obese concentrations enhanced NET production after stimulation with F. nucleatum.  
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Priming 
agent  
Stim-
ulation
 
No stimulation F.nucleatum Opsonised S. 
aureus 
PMA 
TNFa - -  p=0.03  
IL-6 - p=0.01 -  
Adiponectin -  - - 
Leptin -  - - 
Resistin p=0.02  - p=0.02 
 
Table 3.6 Summary of NET MNase quantification after priming concentrations (lean 
& obese) of adipokines and various stimuli. - denotes no significant difference 
between lean and obese adipokine-stimulant ROS production;  denotes a significant 
increase in obese versus lean neutrophils for the stimulant highlighted.  denotes a 
significant decrease in lean versus obese treated neutrophils for the stimulant 
highlighted. 
 
Priming 
agent  
Stim-
ulation
 
No stimulation F.nucleatum Opsonised S. 
aureus 
PMA 
GM-CSF -  - - 
IL-8 -  - - 
 
Table 3.7 Summary of NET MNase quantification after priming concentrations of 
the controls GM-CSF and IL-8 versus stimulus in the absence of any priming agent. 
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Figure 3.13 MNase results with TNFα and IL-6 lean versus obese concentrations 
alone, with S. aureus and with F. nucleatum stimulus.  
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Figure 3.14 MNase results with adipopnectin and leptin lean versus obese 
concentrations alone, with PMA and S. aureus stimulus.  
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Resistin lean versus resistin obese concentrations
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Figure 3.15 MNase results with resistin lean versus obese concentrations alone, with 
PMA and S. aureus stimulus. Results for the control GM-CSF is also shown. 
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Figure 3.16 MNase results for the control IL-8 with PMA and S. aureus stimulus. 
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3.3.3 NET visualisation assay 
 
The NET visualisation assay provides an image backdrop to the MNase assay, where 
NETs formed can be visualised but not quantified. There are clear differences in the 
photos between stimulus and blank but also the NETs formed between the different 
stimuli – F. nucleatum results in thinner extrusions and S. aureus is more rounded in 
appearance and PMA seems to generate long and rounded NETs (figure 3.17). Of the 
images taken with adipokine incubation prior to stimulus, some images reflect the 
quantified results and also the ROS result, for example TNFα lean versus obese – the 
NETs generated from incubation with the obese concentration appear thicker and 
longer than lean (figures 18-21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
 
 
 
 
 
3 Discussion 
 
4 Conclusion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 NET visualisation photos: controls 
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Figure 3.18 NET visualisation photos: IL-6 with F. nucleatum 
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Figure 3.19 NET visualisation photos: TNFα and IL-6 with S. aureus 
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Figure 3.20 NET visualisation photos: adipokines with S. aureus 
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Figure 3.21 NET visualisation photos: adipokines with PMA 
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4. Discussion 
 
This project shows that adipokine concentrations reflective of obese individuals 
appear capable of affecting neutrophil function when challenged with an activating 
stimulus over lean concentrations under certain stimulation conditions. Obese 
concentrations of IL-6, leptin and adiponectin enhanced the ROS potential of 
neutrophils derived from healthy lean males compared to incubation with lean 
concentrations. Furthermore resistin, IL-6 and TNFα were able to increase NET 
production in the neutrophils over stimulus alone. These results suggest a pro-
inflammatory potential of these agents in contributing to the low-grade chronic 
inflammatory phenotype present in obese individuals. Adiponectin, which has 
largely anti-inflammatory roles (as highlighted in table 1.1) is lower in obese 
individuals compared to lean and results of this study support the protective role of 
adiponectin as obese concentrations generated significantly higher ROS than in 
neutrophils pre-incubated with lean concentrations.  
It is important to note the different effects these adipokines can have on neutrophil 
activity, for example, at low concentrations, IL-8 stimulates L-selectin shedding and 
the increased expression of β2 integrins which aid the process of neutrophil arrest 
during migration to the site of inflammation. At higher concentrations the oxidative 
burst is initiated, and higher still IL-8 induces degranulation of neutrophils (Ley 
2002). 
Leptin, resistin and adiponectin concentrations were taken from studies that 
employed ELISAs to determine the lean and obese concentration from blood plasma 
of volunteers, whose numbers ranged from 8 (Rosicka et al. 2003) to 52 people 
(Cohen et al. 2008). In contrast TNFα and IL-6 concentrations were derived from a 
study by Murdolo et al. (2008) that measured in situ profiling of adipokines in 
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subcutaneous microdialysates from 6 lean and 6 obese individuals. How truly 
representative these chosen concentrations are of physiological levels is not clear; 
the literature review (table 3.1) identified a large variation in reported levels of some 
of the adipokines. This could be for several reasons which are outlined below. 
a) Differences in experimental technique, for example Wozniak et al. (1993) 
incubated neutrophils for under 10 minutes prior to and after the addition of 
priming agent and stimuli, and a longer incubation time may generate 
different results. 
b) The sex of the volunteers can impact upon physiological adipokine 
concentration findings, for example, serum leptin levels have been found to 
be significantly higher in healthy women (29.5 ng/ml) than healthy men (4 
ng/ml) (Cohen et al. 2011).  
c) Adipokine levels can differ greatly within sexes, for example a study by 
Illan-Gomez et al. 2012 found adiponectin levels in obese women (5.82 
µg/ml with a SD of 2.93) and lean women (16.68 µg/ml with a SD of 64.17), 
clearly within lean women there is huge variation.  
d) Age differences of the volunteers can impact upon results, for example 
Andreasson et al. 2012 found leptin and adiponectin levels increased with 
advancing age adults. Furthermore older persons tend to have higher fat 
composition and therefore risk assessment by BMI alone is less accurate.  
e) The health status of the volunteers had to be taken into consideration when 
selecting obese and lean concentrations from the literature, for example Onat 
et al. 2008 used volunteers that comprised individuals with disease such as 
type 2 diabetes and coronary heart disease.  
f) The sample in which the adipokine levels were measured (e.g. plasma versus 
serum) can also give varied concentrations in lean and obese individuals. 
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Indeed Murdolo et al. 2008 acknowledge the concentrations of adipokines 
they found may not be truly representable of actual interstitial levels, for 
example, the values were not adjusted for the in vivo recovery factor.  
g) Another challenge when addressing which concentrations to use was those 
found in morbidly obese (BMI > 40 kg/m
2
) versus obese individuals (BMI > 
27 and > 40 kg/m
2
) – ultimately obese levels in otherwise healthy volunteers 
were selected as these studies generally used “healthy” obese – i.e. no other 
accompanying obesity-linked diseases such as type 2 diabetes or 
atherosclerosis. 
 
Another point to consider relates to the “priming concentrations” of adipokines used 
in this project. Some of the studies noted effects of the adipokines on cells other than 
neutrophils, for example Lovren et al. (2010) used monocytes when studying the 
effects of adiponectin. Added to this is the effect of the adipokines on the cells, for 
example Lovren et al. found the effects of adiponectin to be anti-inflammatory (as 
expected), priming human monocytes to differentiate into anti-inflammatory M2 
macrophages. Adiponectin “priming” concentrations in neutrophils would 
presumably lower ROS generation and NET formation; however, due to the low 
numbers of volunteers used in this project, it is not possible to come to any reliable 
conclusion. There were also differences in findings for the influence of adipokines 
on cellular activity; for example, a study by Iqbal et al. (2005) found no difference in 
resistin levels in severe obese individuals after a 6 month dietary intervention 
program.  
Neutrophils are short-lived cells; however the length of time in which they can be 
bathed in adipokines in the body is considerably longer than the 30 minutes used in 
this ex vivo study. Added to this is the fact that these agents do not work in isolation, 
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but rather in complex networks involving both pro and anti-inflammatory effects 
(Preshaw and Taylor 2011). For example, the raised IL-6 levels in obese individuals 
is can be a consequence of TNF-α release, which can trigger IL-6 release and 
increase systemic levels of IL-6 (Peterson and Pedersen 2005). Studies in rodents 
have demonstrated a possible role of leptin in regulating adiponectin; that through 
fasting a state that lowers leptin levels can also lower adiponectin expression in 
adipose tissue, with re-feeding increasing levels (Zhang et al. 2002). The adipokines 
can also show divergent effects depending on their concentration, for example, Van 
Den Berg et al. (2001) showed the effects of TNFα to be dose dependent; at low 
doses (0.1-1 ng/ml) of TNFα neutrophil survival increased, but at higher doses ( 10 
ng/ml) the effect was lost. 
In periodontal pathogenesis cytokines have wide ranging and overlapping functions, 
the balance between pro- and anti-inflammatory cytokines and regulation of their 
receptors and signalling pathways determines the extent of periodontal tissue 
destruction.  
Studies of ROS generation by peripheral blood neutrophils in periodontal disease 
have used a variety of patient groups, pathways of activation, neutrophil isolation 
techniques and differing methods of ROS detection. Results obtained from 
chemiluminescent assays for detecting ROS can show considerable day-to-day 
variation, thus selecting gender and age-matched individuals is important to obtain as 
consistent results as possible. When looking at the integration and peak results it is 
clear there are some outliers and this could mask the identification of potentially 
significant responses, for example there may be a general trend shown by the 
majority of volunteers, however one outlier may prevent statistical significance 
being achieved. 
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All experiments were performed in the presence of divalent cations (Mg
2+
 and Ca
2+
) 
and for ROS glucose, in an attempt to reflect more accurately the in vivo situation. 
This has been used in similar studies of neutrophils (Matthews et al. 2007b) however 
some of the studies identified from the literature review on adipokines affecting 
neutrophil function did not enrich buffers with them, for example Nathan et al. 
(1989) and Cohen et al. (2008) for the studies of GM-CSF and resistin respectively. 
Most public work on cytokine biology and immune responses in periodontitis has 
involved model systems, which are far removed from the microanaomical 
complexity of the human periodontium (Preshaw and Taylor 2011). More 
meaningful in vivo and ex vivo models of periodontits will give a better 
understanding of how the human host responds to a polymicrobial challenge.  
Future work could involve the study of other adipokines, such as apelin, vaspin and 
omentin to provide a more in depth profile of the potential effects of adiopkines on 
neutrophil function in lean versus obese individuals. The stimulation of neutrophils 
via other receptors could also be studied, such as Nod-like receptors (NLRs), which 
are activated by PAMPs such as muramyl dipeptide (MDP) (Franchi et al. 2009), 
which is found on the surface of the peptidoglycan layer  of nearly all Gram positive 
and Gram negative organisms (McDonald et al. 2005). NLR1, NLR2 and NLRP3 are 
expressed by neutrophils and have been shown to bind MDP (Ekman and Cardell 
2009). 
 
5. Conclusion 
 
Adipokine concentrations representative of those found in obese individuals have 
been shown in this pilot study to enhance neutrophil ROS and NET generation after 
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exposure to bacterial stimulus. The effects are however stimulus dependent and 
require longer studies to validate any significant results. 
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Figure S.1 Integration ROS results with adiponectin and leptin with PMA stimulus. 
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Figure S.2 Integration ROS results with resistin and GM-CSF with PMA stimulus. 
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Figure S.3 Integration ROS results with IL-8 with PMA stimulus. 
101 
 
A
rb
it
ra
ry
 U
n
it
s
Adiponectin (13.3 g/ml) + PMA Adiponectin (8.6 g/ml) + PMA
-8000
-6000
-4000
-2000
0
2000
Peak at 60 mins with adiponectin and PMA
A
rb
it
ra
ry
 U
n
it
s
Leptin (6.4 ng/ml) + PMA Leptin (23.45 ng/ml) + PMA
-4000
-2000
0
2000
4000
6000
Peak at 60 mins with leptin and PMA
A
rb
itr
a
ry
 U
n
its
Adiponectin (13.3 g/ml) + PMA Adiponectin (8.6 g/ml) + PMA
0
10000
20000
30000
40000
Peak at 120 mins with adiponectin and PMA
P = 0.002
A
rb
it
ra
ry
 U
n
it
s
Leptin (6.4 ng/ml) + PMA Leptin (23.45 ng/ml) + PMA
0
10000
20000
30000
40000
50000
Peak at 120 mins with leptin and PMA
 P = 0.004
Peak ROS results with lean versus obese concentrations of adiponectin and leptin
with PMA stimulus
 
Figure S.4 Peak ROS results with adiponectin and leptin with PMA stimulus. 
102 
 
A
rb
it
ra
ry
 U
n
it
s
Resistin (12.8 ng/ml) + PMA Resistin (33 ng/ml) + PMA
-3000
-2000
-1000
0
1000
2000
3000
Peak at 60 mins with resistin and PMA
A
rb
it
ra
ry
 U
n
it
s
PMA GM-CSF (100 ng/ml) + PMA
-4000
-2000
0
2000
4000
6000
Peak at 60 mins with PMA versus GM-CSF and PMA
A
rb
it
ra
ry
 U
n
it
s
Resistin (12.8 ng/ml) + PMA Resistin (33 ng/ml) + PMA
0
10000
20000
30000
40000
Peak at 120 mins with resistin and PMA
P = 0.002
A
rb
it
ra
ry
 U
n
it
s
PMA GM-CSF (100 ng/ml) + PMA
0
20000
40000
60000
Peak at 120 mins with PMA versus GM-CSF and PMA
Peak ROS results with lean versus obese concentrations of resistin and control GM-CSF
with PMA stimulus
 
Figure S.5 Peak ROS results with resistin and GM-CSF with PMA stimulus. 
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Figure S.6 Peak ROS results with IL-8 with PMA stimulus. 
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Figure S.7 Integration ROS results with adiponectin and leptin with S. aureus stimulus. 
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Figure S.8 Integration ROS results with resistin and GM-CSF with S. aureus stimulus. 
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Figure S.9Integration ROS results with IL-8 with S. aureus stimulus. 
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Figure S.10 Peak ROS results with adiponectin and leptin with S. aureus stimulus. 
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Figure S.11 Peak ROS results with resistin and GM-CSF with S. aureu s stimulus. 
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Figure S.12 Peak ROS results with IL-8 with S. aureus stimulus. 
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Figure S.13 Integration ROS results with TNFα and IL-6 with F. nucleatum stimulus. 
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Integration at 60 mins with TNF and S. aureus
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Figure S.14 Integration ROS results with TNFα and IL-6 with S. aureu stimulus s. 
112 
 
A
rb
it
ra
ry
 U
n
it
s
2 pg/ml 4 pg/ml
-1000
-500
0
500
1000
Peak at 60 mins with TNF and F. nucleatum Peak at 60 mins with IL-6 and F. nucleatum
A
rb
it
ra
ry
 U
n
it
s
0.5 pg/ml 1.5 pg/ml
-200
0
200
400
600
800
A
rb
it
ra
ry
 U
n
it
s
2 pg/ml 4 pg/ml
0
10000
20000
30000
40000
Peak at 120 mins with TNF and F. nucleatum Peak at 120 mins with IL-6 and F. nucleatum
A
rb
it
ra
ry
 U
n
it
s
0.5 pg/ml 1.5 pg/ml
0
10000
20000
30000
40000
Peak ROS results with lean versus obese concentraitons of TNFa and IL-6
with F. nucleatum stimulus
 
Figure S.15 PeakROS results with TNFα and IL-6 with F. nucleatum stimulus. 
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Figure S.16 Peak ROS results with TNFα and IL-6 with S. aureus stimulus.
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Abstract 
The obesity epidemic is a growing public health problem in all worldwide 
populations. It is well known that obese individuals exhibit low grade chronic 
inflammation which exacerbates obesity-associated diseases. The link between 
obesity and the occurrence and severity of periodontitis is well characterised and 
obesity constitutes a major risk factor for periodontal tissue destruction, however 
direct biological evidence is yet to be established. Adipose tissue, once overlooked 
as simply inert, fat storing cells of the body, has been shown to function in a similar 
way to endocrine organs through the secretion of cytokines (adipokines) can 
contribute towards dysregulated immune responses to bacterial infection. The 
globally secreted cytokines tumour necrosis factor (TNFα) and interleukin-6 (IL-6), 
as well as adipose-specific adipokines resistin, leptin and adiponectin have been 
previously shown to prime/affect neutrophils which are the primary cells involved in 
immunity to periodontal bacteria at sufficiently high concentrations. This study 
aimed to ascertain the effect of these adipokines on neutrophil chemotaxis at 
concentrations reflective of adipokine rich (obese) and adipokine normal (lean) 
individuals. 
Blood was isolated from healthy male volunteers, with no history of diabetes and 
with normal body mass indices BMI’s (range 20-25). Peripheral blood neutrophils 
were isolated by Percoll
TM
 discontinuous gradient centrifugation. The 
chemoattractive properties of these adipokines were investigated using an “Insall” 
chamber by exposing the neutrophils to lean/obese concentrations. Neutrophil 
movement was captured by microscopic imaging. 
The results revealed significant increase in chemotactic index, speed and velocity 
when the neutrophils were pre-incubated with concentrations of adipokines found in 
obese patients relative to non-obese levels. 
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1. Introduction 
 
1.1 Periodontitis  
 
Chronic periodontitis is a major cause of tooth loss in adults and is associated with 
other inflammatory diseases including cardiovascular diseases and type II diabetes 
(Pihilstrom 2005). Chronic periodontitis is thought to arise in pre-disposed 
individuals whose immune systems respond abnormally to the microorganisms that 
contribute to the plaque biofilm found at the dento-gingival junction complex. The 
periodontal tissue comprises gingival epithelium, a highly porous tissue composed of 
junctional epithelial cells alongside gingival connective tissues, periodontal 
ligaments and alveolar bone (Bosshardt and Lang 2005). To cope with constant 
microbial exposure, the gingival cells express numerous host mediators and the 
tissues are infiltrated by innate immune cells, including neutrophils. Approximately 
30,000 neutrophils pass through the periodontal tissues every minute (Schiott and 
Loe 1970). Bacterial challenge at periodontally healthy sites aids immune resistance 
to colonisation of potentially pathogenic microbial species, however at diseased sites 
there is an alteration in these normal defence mechanisms (Darveau 2010).  
The precursor to periodontitis is gingivitis, which requires the presence of plaque 
bacteria (Loe et al. 1965; Theilade et al. 1966) that induce pathological changes in 
the periodontal tissues resulting in the formation of a “lesion”. However not all 
sufferers of gingivitis develop periodontitis.  
Periodontitis is characterised by a microbial-shift  in which Gram positive organisms 
that initially colonise are replaced by Gram negative  (Marsh 1994). The presence 
and persistence of pathogenic bacteria, such as subsets of Porphryromonas 
gingivalis, in high enough numbers can illicit chronic inflammatory responses. The 
abnormal host inflammatory response against the bacteria includes the excessive 
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generation of reactive oxygen species (ROS) and results in connective tissue 
destruction and tooth loss (Chapple and Matthews 2007; The American Academy of 
Periodontology 1999). An aberrant host immune response to this colonisation 
infection drives tissues damage and is responsible for the clinical manifestations of 
the disease which is a result of imbalance or disruption of the inflammatory 
mediators generated in response to infection (Champagne et al. 2003; Van Dyke 
2008).  
Studies of aggressive periodontitis sufferers, who have a distinctly different 
pathogenesis to chronic periodontitis, have been found to have impaired neutrophil 
function characterised by impaired neutrophil chemotactic activity in most cases 
(Clark et al. 1977; Van Dyke et al. 1980; Daniel et al. 1993). The patients suffer 
increased susceptibility to infections and severe periodontal disease. It should be 
noted that these studies used a Boyden chamber, an indirect method that involves 
counting the number of cells that migrate towards a chemoattractant source, and 
results are more likely a reflection of chemokinesis, which is the movement of cells 
in a non-directional fashion. 
 
1.2 The host response to bacterial infection: the neutrophil 
 
Neutrophils are a member of the granulocyte family of white blood cells. They are 
formed in the bone marrow and are terminally differentiated from myeloblasts 
(Amulic et al. 2012). In non-infected individuals the release of neutrophils from the 
bone marrow is tightly regulated and those in circulation are confined to the vascular 
capillaries, however challenge with infectious agents such as bacteria results in a 
shift of the neutrophil into an adherent state involving the migration of cells to and 
subsequent activation  within the site of inflammation. The host immune response to 
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bacterial infection is characterised by infiltration of neutrophils, macrophages, 
lymphocytes and other immune cells into the infected tissues as well as the secretion 
of inflammatory mediators including cytokines and matrix metalloproteinases that 
actively recruit these cells and drive inflammation.  
Cytokines are a diverse group of molecules with potent biological activity whose 
primary function is to regulate immune responses. Neutrophils are the first line of 
innate immune defence against non-specific infectious or chemical agents and are 
recruited to sites of inflammation by chemoattractants secreted by affected tissue 
(Detmers et al. 1996). Products generated from bacteria and other infectious agents 
can also act as chemoattractants such as fMLP (N-formyl-Met-Leu-Phe) and 
lipopolysacharride (LPS) (Chen and Pan 2009). Cell migration from blood vessels to 
the site of infection is the first step in phagocytosis and involves several steps 
including capture, rolling, activation and transcellular movement. The signalling 
molecules phosphatidylinositol 3-kinase (PI3K) and Akt/protein kinase B regulate 
neutrophil migration (Sasaki et al. 2000). Figure 1.1 outlines the process of 
leukocyte transendothelial migration, which occurs in the tight junctions between the 
vascular endothelial cells.  
Chemokines such as interleukin-8 (IL-8) are released in response to inflammatory 
stimuli and attract and activate neutrophils to adhere to and cross the the endothelial 
walls of blood vessels (Huber et al. 1991). Neutrophil chemoattractant receptors are 
members of the transmembrane G-protein coupled receptor family, activation of 
which triggers various signaling cascades that enable the cell to move in a direction-
specific manner to towards the source of the chemoattractant. Receptor-ligand 
binding of these agents results in the activation of protein kinase C, tyrosine kinases 
and the GTP binding protein Ras (Worthen et al. 1994). Activation of further 
proteins within the cell results in the actin-dependent movement of the neutrophil in 
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a gradient-driven manner. The activation of chemoattractant receptors also serves to 
activate phosphoinositol-3-kinase which is involved in NAPDH oxidase activation 
(Klippel et al. 1996).   
 
 
Figure 1.1 Adhesion and migration of leukocytes. Rolling is mediated by selectins. 
Activaiton is mediated by chemokines and arrest via integrins. All three of the major 
steps result in the recruitment of the cell to the endothelial wall and subsequent 
passage out of the vessel (Ley et al. 2007). 
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1.3 Cell migration: chemotaxis 
 
Molecular gradients are an inherent feature of mammalian physiology required to 
activate intracellular signalling events and establishing directional cues for migrating 
cells. Chemotaxis is the process by which the direction of motile cells is biased along 
a concentration gradient of soluble factors/extracellular signals known as 
chemoattractants (Insall 2010). Chemotaxis exists in a large and diverse number of 
organisms from amoebas to eukaryotes (Van Haarstert 2004). Neutrophils migrate to 
the site of infection along a chemoattractive gradient in order to kill invading 
microorganisms. This process involves a number of interacting processes including 
recognition of the chemoattractant, detection of a possible gradient and transmission 
of the information to the cell’s motility machinery. Neutrophils move by producing 
actin-rich pseudopods at the leading edge of the cell while retracting other regions 
The orientation of these protrusions towards a chemoattractant determines the 
direction of migration (Andrew and Insall 2007). Chemokines are divided into four 
structurally similar sub-families (CXC, CX3C, CC and C) (Bonecchi et al. 2009). 
Neutrophils express the chemokine receptors CXCR1 and CXCR2 which bind IL-8 
(CXCL8), GCP2 (CXCL6) and GROα (CXCL1) (Viola and Luster 2008). 
Chemokine receptor-ligand binding activates pathways including MAPKs and 
nuclear factor (NF)-κB. Disturbances in the ability of cells to migrate up a 
chemotactic gradient can increase the risk for bacterial infections.   
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1.4 The resolution of inflammation 
 
The resolution of inflammation is a vital process that limits further infiltration of 
activated cells and removes apoptotic cells from sites of inflammation. Ingestion of 
apoptic cells is driven by anti-inflammatory cytokines such as transforming growth 
factor (TGF)-β and IL-10 (Kennedy and DeLeo 2009). Late in the inflammatory 
response neutrophils switch from producing pro-inflammatory lipid mediators such 
as prostaglandins, to anti-inflammatory lipids which include resolvins and lipoxins. 
The production of these lipids is a result of the interaction of neutrophils with other 
cell types including epithelial cells, fibroblasts, platelets and leukocytes. The anti-
inflammatory lipid mediators promote macrophage infiltration to the site and also 
inhibit neutrophil recruitment and function. Figure 1.2 shows a diagrammatic 
representation of the sequential process of inflammation resolution.  
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Figure 1.2. Proinflammatory mediators and chemoattractants secreted by monocytes 
to recruit other immune cells, particularly neutrophils, to the site of infection 
(Amulic et al. 2012). When the pathogen is no longer detected, a range of other anti-
inflammatory mediators are secreted including resolvins and lipoxins that aid the 
restoration of tissue homeostasis. Neutrophil exposure to anti-inflammatory lipids 
results in the expression of CCR5 on the surface of apoptotic neutrophils, effectively 
“mopping up” free chemoattracitants such as CCL3 and CCL5. This prevents further 
recruitment of neutrophils to the site (Ariel et al. 2006). 
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1.5 Obesity and inflammation 
 
Obesity is a major worldwide medical threat. The number of people “overweight” or 
“obese”, characterised by excessive fat accumulation and defined as a body mass 
index (BMI) of over 25 and 30 respectively, is predicted to be 1.5 billion by 2015 
according to the WHO. Obesity is strongly associated with a number of diseases 
including type II diabetes and coronary heart disease.  
Adipose tissue, which contains the fat-storing cells known as adipocytes, produces a 
number of bioactive molecules that influence and communicate with other organ 
systems and can contribute to systemic inflammation. These so-called adipokines 
have been found to make a significant contribution to chronic low-grade systemic 
inflammation. They include chemokines, complement components, pro-
inflammatory and anti-inflammatory cytokines (Li et al. 2011).  
Adipose tissue comprises adipocytes and cells of the immune system such as 
macrophages, which typically populate 5-10% of the tissue. Roles of macrophages in 
adipose tissue include removing necrotic adipocyte cells (Cinti et al. 2005) and 
forming new blood vessels (Cursiefen et al. 2004). Adipose tissue in obese 
individuals is found to have a significantly higher proportion (up to 60%) of total 
cells within the tissue (Weisberg et al. 2003). The increase in the number of 
macrophages in adipose tissue of obese individuals may contribute to the systemic 
increase in cytokines that are also secreted as adipokines such as TNFα and IL-6 
(Lehrke et al. 2004). The type of macrophages found in adipose tissue of obese 
individuals is different to that of lean people. A study by Lumeng et al. (2007) in 
obese mice identified more of the pro-inflammatory “classically activated” M1 
subsets of macrophages within adipose tissue compared to their lean counterparts 
who had a greater proportion of anti-inflammatory “alternatively activated” M2 
macrophages. 
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Obese individuals have also been found to have elevated systemic concentrations of 
pro-inflammatory cytokines compared to lean (Esposito et al. 2003; Wellen and 
Hotamisligil 2003). Weight loss intervention studies have shown that a reduction in 
body weight, such as through exercise and healthy eating, correlates with a decrease 
in pro-inflammatory and an increase in anti-inflammatory adipokines ( Bastard et al. 
2000; Nicoletti et al. 2003; Ziccardi et al. 2002). 
 
1.6 The role of adipokines 
 
The adipokines investigated in this project include adiponectin, leptin, resistin, TNFα 
and IL-6. Each of these are briefly described below: 
 
Adiponectin is a 244-residue protein that circulates in blood in different molecular 
forms. It is the most abundant adipokine secreted by adipocytes accounting for 
0.01% of total plasma proteins (Maeda et al. 1996). It exists as three major 
oligomeric complexes in the blood stream: trimers, hexamers and a high-molecular 
weight form (Arita et al. 1999). Obese subjects have low plasma levels of 
adiponectin compared to lean (Arita et all. 1999) as large adipocytes in obese 
individuals produce lower levels of adiponectin (Berg and Scherer 2005). 
Adiponectin has been shown to have protective anti-inflammatory properties, for 
example by stimulating the production of the anti-inflammatory cytokine IL-10 in 
macrophages (Wulster-Radcliffe et al. 2004) and the ability to switch macrophages 
from the M1 to M2 phenotype (Ohashi et al. 2010). Studies have also shown 
adiponectin reduces the expression of pro-inflammatory TNFα in adipose tissue 
(Maeda et al. 2002), inhibits macrophage phagocytic activity and attenuates pro-
inflammatory signalling pathways such as nuclear factor (NF)-κB (Ouchi et al. 2000; 
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Wulster-Radcliffe et al. 2004). Other roles of adiponectin include increasing fatty 
acid oxidation and decreasing gluconeogenesis in the liver (Lago et al. 2007). The 
administration of adiponectin in diabetic mice enhances insulin sensitivity through 
the reduction of hyperglycaemia, indicating the proteins role in protecting against 
obesity-linked metabolic dysfunction (Berg and Scherer 2005). The mechanism by 
which adiponectin protects against insulin sensitivity is through activation of 
antimicrobial peptide (AMP)-activated protein kinase in the liver and skeletal 
muscle, which leads to an increase in glucose uptake and fatty acid oxidation 
(Yamauchi et al. 2002). Plasma adiponectin levels are also negatively associated 
with C-reactive protein, a marker of low-grade inflammation, in obese individuals, 
whereas the reverse is true for healthy lean individuals (Ouchi et al. 2003). 
 
Leptin is a 16-kDa non-glycosylated peptide member of the class I cytokine 
superfamily. It is expressed by inflammatory cells exposed to stimuli such as IL-6 
and LPS (Faggioni et al. 2001) and it functions in regulating appetite, energy 
homeostasis and immune and inflammatory processes in macrophages, neutrophils 
and other immune cells (Otero et al. 2006; Matarese et al. 2005). Upon binding to its 
receptors, of which there are two isoforms (Ob-Ra and Ob-Rb) intracellular 
pathways including JAKs, STAT1 and NF-κB are activated (Eder 2009). Ob-Ra, the 
short form of the leptin receptor is expressed on neutrophils, whereas the long 
isoform Ob-Rb, is expressed by monocytes (Zarkesh-Esfahani et al. 2004).  Leptin 
has been shown to increase the production of TNF and IL-6 in monocytes and 
stimulates chemokine ligand production in macrophages (Santos-Alvarez et al. 1999; 
Kiguchi et al. 2009). A diet deficient in essential nutrients correlates with low leptin 
levels and this is associated with immune impairment and increased susceptibility to 
infection.  
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Resistin is a 12.5-kDa dimeric protein mainly expressed in neutrophils and 
macrophages (Patel et al. 2003). LPS has been shown to induce the expression of 
resistin in macrophages. IL-6 and TNFα can induce and be induced by resistin 
secretion (Bokarewa et al. 2005) indicating its role as a pro-inflammatory cytokine. 
 
Tumour necrosis factor (TNFα) is produced by a number of cell types, particularly 
macrophages and T lymphocytes, but also neutrophils and osteoclasts (Ware 2008). 
TNFα is a pro-inflammatory cytokine and upon binding to either of its two receptors 
(TNFR1 and TNFR2) activates the MAPKs and NF-κB (Locksley et al. 2001). TNFα 
increases expression of cell adhesion molecules such as E-selectin and ICAM-1 on 
the surface of vascular endothelial cells (Bradley 2008), which enable neutrophils to 
bind to these integrins expressed on activated endothelial cells via complementary 
neutrophil receptors such as LFA-1. 
 
IL-6 is a pro-inflammatory cytokine produced by many immune cells including 
adipocytes. IL-6 promotes bone resorption, stimulates angiogenesis and the release 
of acute phase proteins (Blanchard et al. 2009).  
 
 
1.7 Obesity and periodontitis 
 
Obesity has emerged as one of the major risk factors for periodontal disease and 
many studies have demonstrated this association in both young, middle aged and 
older people (Al-Zahrani et al. 2003, Dalla Vecchia et al. 2005, Ekuni et al. 2008, 
Khader et al, 2009, Kongstadt et al. 2009, Saito et al. 2005). A recent study by 
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Dickie de Castilhos  et al. (2012) identified an association between young obese 
individuals and an increased incidence of gingivitis, which is a risk factor for 
periodontitis. It appears the distribution of fat is associated with the risk of 
periodontitis, in particular visceral fat accumulation (Saito et al. 2001).  
The mechanism linking obesity with chronic inflammatory diseases such as 
periodontitis is thought to be mediated by adipokines secreted form adipose tissue.  
Adipose dysfunction as a consequence of adipose tissue expansion can have local 
and systemic effects on inflammatory responses, which can contribute to the 
initiation and progression of inflammatory-linked diseases. One such consequence is 
the resorption of alveolar bone, which is a hallmark of periodontitis. This is caused 
by the increased expression of RANKL (receptor-activator of nuclear factor-κB 
ligand), which binds osteoclast pre-cursors and causes them to differentiate into bone 
resorbing cells (Cochran 2008). RANKL can be induced by TNFα and IL-1β 
(Nagasawa et al. 2007). 
 
1.8 The effect of adipokines on chemotaxis 
 
Numerous studies have shown that adipokines affect cellular behaviour, for example 
pro-inflammatory adipokines can activate neutrophils or “prime” them for the 
enhanced generation of reactive oxygen species (ROS) as described in project 1 
section 1.7. Below are a few examples of studies that have demonstrated the effects 
of non-physiological concentrations of the adipokines used in this study specifically 
on neutrophil chemotaxis.  
A study by Okamoto et al. 2008 showed the ability of anti-inflammatory adiponectin 
to inhibit CXCR3 chemokine ligands in monocyte-derived macrophages at 
concentrations ranging from 0.01- 10 µg/ml after stimulation with LPS.   
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Leptin has been shown to act as a neutrophil chemoattractant showing maximal 
response at 50 ng/ml in a study by Montecucco et al. (2006) showed neutrophils 
exposed to leptin induced chemotaxis but did not lead to cell activation because of a 
lack of intracellular calcium mobilisation and oxidant production. The study also 
showed intracellular pathways in leptin-mediated chemotaxis involve the activation 
of p38 MAPK. Another study showed leptin induced neutrophil chemotaxis towards 
fMLP and also acted as a chemotactic agent at a much higher concentration (250 
ng/ml) (Caldelfie-chezet et al. 2003).   
Resistin at a concentration of 30 nM has been shown to induce neutrophil arrest and 
the expression of cell adhesion molecules including VCAM-1 and ICAM-1 
(Kawanami et al. 2003), which occurs during the leucocyte migration cascade. 
GM-CSF is a cytokine released by different cell types including activated T cells and 
macrophages (Arai et al. 1990). As well as its other pro-stimulatory effects on 
neutrophils, GM-CSF can induce the expression of neutrophil receptors for CC 
chemokines (Cheng et al. 2001). GM-CSF has been shown to induce neutrophil 
chemotaxis and chemokinesis of neutrophils at a maximally effective concentration 
of 60 ng/ml. This response was similar to that of the chemokine IL-8 (also at 60 
ng/ml) however both IL-8 and GM-CSF were less potent than fMLP (Gomez-
Cambronero et al. 2003).  
TNFα at high concentrations has been shown to act as a chemoattractant for 
neutrophils (Shalaby et al. 1985). In particular, studies Gamble et al. (1985) and 
Ming et al. (1987) showed the ability of neutrophils to adhere to the endothelium of 
umbilical cord veins when pre-incubated with TNFα at concentrations up to 10,000 
Units/ml.  
If chemokines are not removed from the site of inflammation or sufficient quantities 
of anti-inflammatory chemokines are not produced, resolution of inflammation can 
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be compromised. Obese individuals have higher circulating adipokines than lean, 
and these adipokines at higher concentrations than those found phsiologically have 
chemotactic properties. If physiological concentrations show also to have an effect 
on chemotaxis, this could be one of the factors that prevent the efficient end of 
inflammatory resolution and could therefore contribute to the chronic low-grade 
inflammatory state present in obese individuals..  
 
1.9 Methods of studying neutrophil chemotaxis  
 
The purpose of studying chemotaxis is to allow the behaviour of cells subjected to a 
linear gradient of chemoattractant to be observed directly using a light microscope. 
Most assays use the two-well design whereby cells are seeded between the wells, one 
containing a control or buffer substance and the other with the chemoattractant and 
cells lying within the gradient are able to migrate between them. This enables the 
study of chemokinesis. However direct visualisation chambers allow cells to be 
observed migrating using time-lapse microscopy in real-time and are considered the 
gold standard for investigating true “chemotaxis” (Wells 2000). Bridge chambers 
provide a visualisation platform for observing the behaviour of cells between the two 
wells; the cells are plated onto coverslips which are inverted leaving a gap between 
the chamber and coverslip for the addition of desired chemoattractant. They include 
the Zigmond, Dunn and Insall chambers, which are briefly described below and 
illustrated in figure 1.3. 
- The Zigmond chamber was first described in 1977 for the study of 
polymorphonuclear cells (Zigmond 1977). The chamber permits the 
generation of shallow gradients at a near steady state linear gradient. The 
Zigmond chamber has a variable gap between the bridge and coverslip which 
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can result in unpredictable variations in the chemotactic gradient (Zicha et al. 
1991).  
- The Dunn chamber is derived from the original Zigmond chamber and 
achieves stability by being a sealed, rigid, glass enclosure entirely filled with 
incompressible medium using thick (0.25-0.35 mm) coverslips. The circular 
bridge design can result in variable chemoattractant gradient orientation and 
changing the gradient in Dunn chambers is inefficient (Muionen-Martin 
2010). 
- The Insall chamber, derived from the Dunn chamber (Muinonen-Martin et al. 
2010), is designed to ensure better stability between the gap between the 
bridge and coverslip. The bridge structure is a square arrangement with two 
linear bridges of differing widths on opposite sides and the other two sides 
are large coverslip supports. The ease of handling, gradients with defined 
directions and the ability to use thin coverslips are some of the advantages of 
this type of bridge chamber. The Insall chamber was used in this project. 
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Figure 1.3. The major bridge chambers commercially available. The Insall chamber 
is the most recently developed chamber and offers advantages over the Dunn and 
Zigmond. A) shows the schematics of all three chambers – both Zigmond and Dunn 
lack a support structure for the coverslip. B) The desired chemoattractant can be 
loaded into the Insall chamber once the coverslip is attached. C) The differences in 
bridge widths provide different gradient steepnesses. D) The gradients are 
unidirectional across each bridge (Muinonen-Martin et al. 2010). 
 
 
 
 
17 
 
1.10 Project aims 
 
The aim of this project was: 
- To investigate the chemotactic potential of the adipokines, resistin, 
adiponectin, leptin, IL-6 and TNFα at concentrations found in obese and lean 
individuals using a novel directional chemotaxis assay – the “Insall 
Chamber”. 
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2. Methods 
2.1 Blood collection 
 
Blood was taken from staff and student volunteers of the Birmingham Dental 
School. Volunteers had a BMI and waist-hip ration within the normal range 
(22.06±0.22 and 0.86±0.005 respectively). All were under 30, non-smokers, non-
diabetic males and not taking any anti-inflammatory medication. Approximately 25 
ml of blood was collected from each volunteer into Vacutainer
TM
 (Greiner Bio-One 
Ltd, Stonehouse, UK) lithium heparin (17 IU/ml) tubes. The tubes were inverted 
several times and after a time lapse of approximately 20 minutes the blood was 
removed from the tubes for neutrophil isolation. Donors gave their consent and 
ethical approval was provided by the University of Birmingham (ERN_10-0518).  
 
2.2 Neutrophil isolation 
 
Neutrophils were isolated from blood samples using percoll (GE Healthcare) and a 
full description is given in project 1 (section 2.3).  
 
2.3 Adipokines 
 
A literature review to identify the lean and obese concentrations of adipokines used 
in this project was performed (the details of which are shown in table 3.1 of project 
1). The chosen concentrations and references are shown in table 2.1. GM-CSF and 
IL-8 were used as positive controls and therefore concentrations were chosen that 
have been shown in previous studies to affect neutrophil behaviour. 
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Table 2.1 Lean and obese concentrations of adipokines used in this project. 
 
 
 
 
Adipoki
ne 
Lean 
concentratio
n 
Reference 
for lean 
concentratio
n 
Obese 
concentratio
n 
Reference 
for obese 
concentratio
n 
Priming 
concentratio
n 
Reference 
for priming 
concentratio
n 
TNFα 2 pg/ml 
Murdolo et al. 
2008 4 pg/ml 
Murdolo et al. 
2008     
IL-6 0.5 pg/ml 
Murdolo et al. 
2008 1.5 pg/ml 
Murdolo et al. 
2008     
Adiponectin 13.3 μg/ml 
Silha et al. 
2003 8.6 μg/ml 
Silha et al. 
2003     
Leptin 6.4 ng/ml 
Rosicka et al. 
2003 23.45 ng/ml 
Rosicka et al. 
2003     
Resistin 12.8 ng/ml 
Cohen et al. 
2008 33 ng/ml 
Cohen et al. 
2008     
IL-8 (positive 
control)         10 ng/ml 
Wozniak et 
al. 1993 
GM-CSF 
(positive 
control)         100 ng/ml Nathan 1989 
20 
 
2.4 Chemotaxis assay 
 
For the chemotaxis assay, the isolated neutrophils were required at a concentration of 
2 x 10
6
 per ml suspended in RPMI. 1.5 µl of 7.5% Albumin Bovine Fraction (Sigma: 
A8412) was also added per ml of cell suspension. Coverslips were washed in 0.2 M 
HCl followed by sterile water and placed on filter paper. The coverslips were coated 
in 500 µl of 7.5% serum Albumin Fraction and subsequently loaded with 400 µl of 
the neutrophil suspension and incubated for 30 minutes at room temperature.  
The Insall chamber (Muinonen-Martin et al. 2010) was used to study chemotaxis. 
The chamber was washed 4 times with approximately 400 µl of RPMI before a large 
droplet of RPMI was left on the chamber. After the 30 minute incubation, the 
coverslip was inverted and placed at the top of the chemotaxis chamber ensuring that 
the pipette loading bays were exposed. Using filter paper, excess fluid surrounding 
the coverslip was absorbed and the fluid within the chemoattractant wells was 
removed. Finally 80 µl of desired chemoattractant (adipokine or control) were 
injected into the chemoattractant well and analysed by microscopy. The chamber 
was viewed using a Zeiss Primovert microscope at x 40 magnification and images 
were captured using a Q Imaging Retiga 2000R camera. 
 
2.5 Image analysis 
 
The images were processed using Q proimaging software. Images were generated 
every 12 seconds for a total of 36 frames per condition and each stack of images 
were generated within an 8 minute time frame. For each adipokine concentration 5 
image stacks were captured. 
The images were analysed further using Image J 1.45SR software. The manual 
tracking plug-in was used and for each set of images 10 cells were chosen and 
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tracked through the 36 frames. The numerical data generated was then exported into 
excel and averaged to calculate: 
a) Cell speed: which measures the movement of each cell between frames in 
any direction (chemokinesis). 
b) Cell velocity: a measure of the movement of a cell in a focused direction 
(chemotaxis). 
c) Cell persistence: a measure of the commitment of the cell in a particular 
direction (as illustrated in figure 2.1). 
d) Chemotactic index: a measure of the accuracy of orientation towards a 
chemoattractant. 
These measurements have been calculated as derived from those of Sapey et al. 
(2011). 
Statistical analysis of all four parameters of lean versus obese adipokine 
concentrations was done using Prism 5.0 software and any significance difference 
was detected by the non-parametric Wilcoxon rank-sum test.  
It should be noted that calculation of the persistence and chemotactic index results 
are not fully understood, and the results shown for them in the next section does not 
fully complement the other results (chemotactic speed or velocity) or the qualitative 
results (images). 
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Figure 2.1. The parameter persistence as a measure of chemotaxis. The more linear 
the cell track, the greater the persistence. 
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3. Results 
 
3.1 Chemotactic speed 
 
Chemotactic speed is a measure of how far a cell has moved from the beginning 
image to the end frame of an experiment. Table 3.1 shows a summary of the 
significant differences in the speed of the cells between two different agents 
(adipokine or other). Figures 3.1a-f show the raw data of chemotactic speed using 
lean and obese concentrations of adipokines, the positive stimuli GM-CSF and IL-8 
and control (RPMI).  
As expected there was a significant difference between the negative control and the 
positive control chemoattractant fMLP (P = <0.0001 shown in figure 3.1a). The 
same was true of the positive controls GM-CSF and IL-8 (P = 0.0007 and P = 0.0002 
respectively) shown in table 3.1 and figure 3.1f. Adiponectin in both lean and obese 
conditions increases neutrophil speed compared to RPMI (P= 0.003 and < 0.0001 
respectively) however there was no significant difference in neutrophil speed 
between the two concentrations (table 3.1 and figure 3.1a). Leptin showed a similar 
effect (P = 0.001 and < 0.0001) as did IL-6 (P = 0.04 and 0.0003) for lean and obese 
levels respectively (table 3.1 and figures 3.1b and 3.1c). Resistin showed a 
significant increase for lean and obese concentrations compared to RPMI (P = 
<0.001 and 0.0001 respectively) however resistin lean caused a significant increase 
in neutrophil speed compared to obese (P = 0.005) as illustrated in figure 3.1c. TNFα 
lean and obese levels increased cell speed over RPMI controls (P = 0.0001 for both) 
and obese was significantly increased over lean (table 3.1 and figure 3.1d)  
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      Column 1                   vs.         Column 2 
P value Adipokine/RPMI Adipokine/stimulus 
RPMI fMLP < 0.001 
RPMI Adiponectin lean (13.3 µg/ml) 0.003 
RPMI Adiponectin obese (8.6 µg/ml) < 0.0001 
RPMI Leptin lean (6.4 ng/ml) 0.001 
RPMI Leptin obese (23.45 ng/ml)  < 0.0001 
RPMI Resistin lean (12.8 ng/ml) < 0.001 
RPMI Resistin obese (33 ng/ml) 0.0001 
Resistin lean (12.8 ng/ml) Resistin obese (33 ng/ml) 0.005*  
RPMI TNFα lean (2 pg/ml)  0.0001 
RPMI TNFa obese (4 pg/ml) 0.0001 
TNFα lean (2 pg/ml) TNFa obese (4 pg/ml) 0.6 
RPMI IL-6 lean (0.5 pg/ml) 0.04 
RPMI IL-6 obese (1.5 pg/ml) 0.0003 
RPMI GM-CSF (100 ng/ml) 0.0007 
RPMI IL-8 (10 ng/ml) 0.0002 
 
Table 3.1 Significant results from the measurement of chemotactic speed. Increases 
arise from statistical comparison of column 2 compared with column 1. The 
exception is highlighted (*) which represents a significant decrease in speed in 
column 2 compared to column 1. 
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3.1 a)  Speed with adiponectin 
3.1 b) Speed with leptin 
3.1 c) Speed with resistin 
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3.1 d) speed with TNFα 
3.1 e) Speed with IL-6 
3.1 f) Speed with IL-8 and GM-CSF 
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3.2 Chemotactic velocity 
 
Chemotactic velocity is a measure of a cell’s movement in a particular direction, i.e. 
towards a chemoattractant. Table 3.2 displays the statistically significant data from 
analysis of velocity results. Figures 3.2a-f illustrates all velocity results of the 
different adipokine concentrations. All three positive controls (fMLP, GM-CSF and 
IL-8) showed increased velocity compared to RPMI conditions (P = 0.002, 0.03 and 
0.005 respectively) as shown by table 3.2 and figures 3.2a and 3.2f. There were no 
differences between lean and obese conditons, whilst TNFα at obese conncentrations 
appeared to generate a higher velocity relative to lean levels, the variation in 
neutrophil responses in the leaner group negated statistical significance being 
reached. Interestingly, IL-6 obese appeared to enhance neutrophil chemotactic 
velocity over that of fMLP (figure 3.2e). 
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      Column 1                   vs.         Column 2 
P value Adipokine/RPMI Adipokine/stimulus 
RPMI fMLP 0.0002 
RPMI Leptin lean (6.4 ng/ml) 0.0008 
RPMI Resistin lean (12.8 ng/ml) 0.001 
RPMI TNFa obese (4 pg/ml) 0.0002 
RPMI IL-6 lean (0.5 pg/ml) 0.0003 
RPMI IL-6 obese (1.5 pg/ml) 0.0002 
RPMI GM-CSF (100 ng/ml) 0.03 
RPMI IL-8 (10 ng/ml) 0.005 
 
Table 3.2 Significant results from the measurement of chemotactic velocity. 
Increases arise from statistical comparison of column 2 compared with column 1. 
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3.2 a) Velocity with adiponectin 
3.2 b) Velocity with leptin 
3.2 c) Velocity with resistin 
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3.2 d) Velocity with TNFα 
3.2 e) Velocity with IL-6 
3.2 f) Velocity with IL-8 and GM-CSF 
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3.3 Chemotactic persistence 
 
Chemotactic persistence measures how committed the cells are to a particular 
direction. Figures 3.3a-f illustrates the persistence results. The only significant 
results was a decrease between adipokine lean and obese concentrations in leptin, 
when the lean condition increased neutrophil persistence (P = 0.005) as shown in 
figure 3.3b. 
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3.3 a) Persistence with adiponectin 
3.3 b) Persistence with leptin 
3.3 c) Persistence with resistin 
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Persistence with TNF
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3.3 d) Persistence with TNFα 
3.3 e) Persistence with IL-6 
3.3 f) Persistence with GM-CSF and IL-8 
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3.4 Chemotactic index 
 
Chemotactic index measures how accurate the orientation of a cell is towards a 
chemoattractant. Table 3.3 shows the statistical results and figures 3.4a-f illustrates 
all results; the lower the score, the greater the index. fMLP, GM-CSF and IL-8 again 
show significant differences demonstrating fMLP having a higher chemotactic score 
than the neutrophils exposed to RPMI (P = 0.002, 0.04 and 0.03 respectively) (table 
3.3 and figures 3.4a and f). Lean and obese concentrations of adiponectin, leptin and 
TNFα give a greater chemotactic index than control (table 3.3). Both leptin and IL-6 
lean concentrations gave a lower index compared to lean (P= 0.005 and P = 0.04 
respectively) (table 3.3 and figure 3.4e). 
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        Column 1           vs.          Column 2 
P value Adipokine/RPMI Adipokine/stimulus 
RPMI fMLP 0.002 
RPMI Adiponectin lean (13.3 µg/ml) 0.04 
RPMI Adiponectin obese (8.6 µg/ml) 0.05 
RPMI Leptin lean (6.4 ng/ml) 0.0005 
Leptin lean (6.4 ng/ml) Leptin obese (23.45 ng/ml) 0.005* 
RPMI TNFα lean (2 pg/ml) 0.01 
RPMI TNFa obese (4 pg/ml) 0.0003 
IL-6 lean (0.5 pg/ml) IL-6 obese (1.5 pg/ml) 0.04* 
RPMI GM-CSF (100 ng/ml) 0.04 
RPMI IL-8 (10 ng/ml) 0.03 
 
Table 3.3 Chemotactic index. Significant results from the measurement of 
chemotactic index. Statistical comparison of column 2 compared with column 1 were 
made. The exception is highlighted (*) which represents a significant decrease in 
chemotactic index in column 2 compared to column 1. 
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3.4 a) Chemotactic index with adiponectin 
3.4 b) Chemotactic index with leptin 
3.4 c) Chemotactic index with resistin 
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3.4 d) Chemotactic index with TNFα 
3.4 e) Chemotactic index with IL-6 
3.4 a) Chemotactic index with GM-CSF and IL-8 
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3.5 Chemotaxis cell tracking images 
 
Figures 3.4a-3.7a shows the end time-point images of the neutrophils with the 
coloured lines mapping the cell tracks from their origin. White arrows indicate the 
general direction the cell. Figures 3.5b-3.7b show the cell tracks from (derived from 
figures 3.4b-3.7a) all of which have the same point of origin. The images provide a 
qualitative visual as a backdrop to the quantitative chemotaxis parameters (velocity. 
Speed and chemotactic index).  
RPMI, positive control fMLP, TNFα lean and TNFα obese figures are shown. There 
are clear differences in the movement of the cells exposed to RPMI and fMLP, with 
fMLP neutrophils showing a directional movement upwards (towards the source of 
the chemoattractant) and covering a greater distance. TNFα was included because for 
speed, velocity and chemotactic index there were significant differences between 
lean or obese and RPMI control concentrations (figures 3.1d. 3.2d and 3.4d) and also 
obese concentrations enhanced the overall speed of the neutrophils compared to lean 
(3.1d). Apart from a few outliers, the majority of the cells exposed to TNFα obese 
concentrations are orientated in an upward direction compared to lean, which shows 
a speed similar to obese but in a more random direction. Supplementary figures (S.1-
5) show images of neutrophils treated with other adipokines and their movement 
from a common point of origin.     
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Figure 3.5 a) Final image of neutrophils with RPMI control. RPMI was injected into 
the Insall chamber channels, of which the closest point to the channel edge is 
indicated by the orange bar. b) The movement of the cells arranged from a single 
point of origin. The graph has been drawn with RPMI source at the top. 
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Figure 3.6 a) Final image of neutrophils with fMLP postive control. The source of 
the fMLP was towards the top of the image (indicated by the orange bar). b) The 
movement of the cells arranged from a single point of origin. The graph has been 
drawn with fMLP source at the top. 
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Figure 3.7 a) Final image of neutrophils with TNFα lean (2 pg/ml). The source of the 
TNFα was towards the top of the image (indicated by the orange bar). b) The 
movement of the cells arranged from a single point of origin. The graph has been 
drawn with the TNFα source at the top. 
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Figure 3.8 a) Final image of neutrophils with TNFα obese concentration (4 pg/ml). 
The source of the TNFα was towards the top of the image (indicated by the orange 
bar). b) The movement of the cells arranged from a single point of origin. The graph 
has been drawn with TNFα source at the top. 
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4. Discussion 
 
This project shows that adipokines reflective in lean and obese individuals can affect 
chemotaxis in neutrophils. Within all four of the chemotactic parameters studies, 
speed and velocity, which show a similar pattern for the different adipokines, give a 
significant result for the majority of concentrations versus control (RPMI). fMLP 
was shown to significantly increase neutrophil speed, velocity and have a greate 
chemotactic index compared to control and therefore serves to validate the rest of the 
results. GM-CSF and IL-8, the concentrations of which were that of “priming” (and 
therefore non-physiological) also showed significant increases in speed, velocity and 
chemotactic index, but not to the extent of fMLP (which is also supportive of the 
study by Gomez-Cambronero et al. 2003). The two adipokines that showed 
significant differences between lean and obese concentrations were resistin and 
TNFα. For resistin, the results in this study show cell speed to be higher with 
exposure to lean versus obese. This supports the study by Kawanami et al. (2003), in 
which resistin induced cell cycle arrest and the up-regulated expression of adhesion 
factors (which bind to the endothelial cell walls). Conversely TNFα obese 
concentrations were found to significantly increase neutrophil movement compared 
to lean and for obese were comparable to the effects of fMLP, this result also 
supports those within the literature, which show TNFα to act as a positive 
chemoattractant at high concentrations (Shalalby et al. 1985). Justification for the 
concentrations of all adipokines used in this study is described in project 1 (section 
4). 
The results show that these adipokines can affect neutrophil movement. It is likely 
that rather than causing chemotaxis, these agents can induce chemokinesis, (non-
directional cell movement). This would explain the lack of statistically significant 
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results for persistence, which is a measure of cell commitment to a particular 
direction. 
The methods used to analyse the data were adapted from Sapey et al. (2011), 
however there were some differences, such as the length of time between each image 
captured, in this study it was every 12 seconds (Sapey et al. had a 20 second time 
lapse betwwen each frame taken). The results therefore may have been more 
informative if a great time gap had been used. The number of volunteers for this 
study was 5 per adipokine concentration, whereas Sapey et al. used up to 20. An 
increase in the number of volunteers would potentially give a more reliable and 
accurate result.    
The methods used to calculate the chemotactic parameters in this project were from 
using ImageJ software using the plugin ‘Manual Tracking’. This involves manually 
selecting cells and following their movement through a stack of images. The 
subjective nature of this method could generate biased and inaccurate results (despite 
the fact the cells were chosen at random). The cells moved in and out of phase within 
the images and therefore accurately establishing the location and the centre-most 
point of the cell can be difficult. Other methods of analysing chemotaxis activity are 
also available, such as the McCutcheon Index, which measures the length of the path 
travelled toward the chemoattractant minus the distance travelled away from the 
chemoattactant, this is then divided by the total distance travelled (McCutcheon 
1946). Exploring the different methods of assimilating the data derived from 
videomicroscopy will aid deeper understanding and provide a more reliable 
interpretation of the data.  
In this project the Insall chamber was used to study the behaviour of neutrophils 
exposed to different concentrations of adipokines. This chamber was chosen over 
others available (as outlined in section 1.9) as it was deemed the most accurate in 
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terms of establishing a gradient within a defined direction. However these gradients 
are shallow and therefore the results shown in this project showing neutrophil 
migration are unlikely to reflect the complex three-dimensional environment of the 
human body.  
There are other systems outside the use of chambers that are used for the study of 
chemotaxis. Polydiemthylsiloxane (PDMS)-based microfluidic channels are thought 
to provide a better method because there is more control with regard to the spatial 
and temporal characteristics of the chemical environment to which the cells are 
exposed compared to the chamber techniques (Pihl et al. 2005). Figure 4.1 shows the 
schematic representation of the microfluidic device. Future work could involve the 
use of microfluidic devices to study neutrophil chemotaxis. Other adipokines such as 
visfatin, which has been shown to induce chemotaxis in monocytes (Moschen et al. 
2007), could also be explored to generate a profile characterising the differences 
between the effects of lean and obese concentrations. 
 
5. Conclusion 
 
The exposure of neutrophils derived from lean healthy male volunteers to adipokine 
concentrations relfective of lean and obese individuals result in an increase in 
chemokinesis and potentially chemotaxis. More repeats of these studies and 
exploration into other methods of analysing chemotaxis data are required in order to 
validate any significant results.  
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Figure 4.1 An illustration of a microfluidic device. The PDMS piece (which features 
embedded channels) is bonded to a glass coverslip. Chemoattractant and/or medium 
is added to the inlets and as the fluid flows through the channels, different 
concentration gradients are generated for the cells to move towards or away 
depending on the nature of the agent added (Jeon et al. 2002). 
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7. Supplementary results  
 
S.1a) 
 
 
S.1b) 
Figure S.1 a) Photograph of tracking paths of neutrophils exposed to IL-6 obese 
concentration (data is representative of a single volunteer). b) Tracks taken from a) 
and plotted from a single point of origin.  
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S.2a) 
 
 
S.2b) 
Figure S.2 a) Photograph of tracking paths of neutrophils exposed to IL-8 (data is 
representative of a single volunteer). b) Tracks taken from a) and plotted from a 
single point of origin.  
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Figure S.3 a) Photograph of tracking paths of neutrophils exposed to leptin obese 
concentration (data is representative of a single volunteer). b) Tracks taken from a) 
and plotted from a single point of origin. 
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Figure S.4 a) Photograph of tracking paths of neutrophils exposed to resistin lean 
concentration (data is representative of a single volunteer). b) Tracks taken from a) 
and plotted from a single point of origin. 
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S.5b) 
Figure S.5 a) Photograph of tracking paths of neutrophils exposed to resistin obese 
concentration (data is representative of a single volunteer). b) Tracks taken from a) 
and plotted from a single point of origin. 
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